<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd"> 
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="research-article"><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1-3.dtd?><?SourceDTD.Version 1.3?><?ConverterInfo.XSLTName jats2jats3.xsl?><?ConverterInfo.Version 1?><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Int J Mol Sci</journal-id><journal-id journal-id-type="iso-abbrev">Int J Mol Sci</journal-id><journal-id journal-id-type="publisher-id">ijms</journal-id><journal-title-group><journal-title>International Journal of Molecular Sciences</journal-title></journal-title-group><issn pub-type="epub">1422-0067</issn><publisher><publisher-name>MDPI</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">9779433</article-id><article-id pub-id-type="doi">10.3390/ijms232415713</article-id><article-id pub-id-type="publisher-id">ijms-23-15713</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Heterologous Expression Reveals Ancient Properties of Tei3&#x02014;A VanS Ortholog from the Teicoplanin Producer <italic toggle="yes">Actinoplanes&#x000a0;teichomyceticus</italic></article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Yushchuk</surname><given-names>Oleksandr</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Formal analysis" vocab-term-identifier="https://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Visualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/visualization/">Visualization</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x02013; original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#x02013; original draft</role><xref rid="af1-ijms-23-15713" ref-type="aff">1</xref><xref rid="af2-ijms-23-15713" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name><surname>Zhukrovska</surname><given-names>Kseniia</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role><xref rid="af2-ijms-23-15713" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0001-5904-5957</contrib-id><name><surname>Ostash</surname><given-names>Bohdan</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role><xref rid="af2-ijms-23-15713" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name><surname>Fedorenko</surname><given-names>Victor</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Supervision" vocab-term-identifier="https://credit.niso.org/contributor-roles/supervision/">Supervision</role><xref rid="af2-ijms-23-15713" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0001-9195-6777</contrib-id><name><surname>Marinelli</surname><given-names>Flavia</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Supervision" vocab-term-identifier="https://credit.niso.org/contributor-roles/supervision/">Supervision</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x02013; original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#x02013; original draft</role><xref rid="af1-ijms-23-15713" ref-type="aff">1</xref><xref rid="c1-ijms-23-15713" ref-type="corresp">*</xref></contrib></contrib-group><contrib-group><contrib contrib-type="editor"><name><surname>Arabski</surname><given-names>Micha&#x00142;</given-names></name><role>Academic Editor</role></contrib></contrib-group><aff id="af1-ijms-23-15713"><label>1</label>Department of Biotechnology and Life Sciences, University of Insubria, 21100 Varese, Italy</aff><aff id="af2-ijms-23-15713"><label>2</label>Department of Genetics and Biotechnology, Ivan Franko National University of Lviv, 79005 Lviv, Ukraine</aff><author-notes><corresp id="c1-ijms-23-15713"><label>*</label>Correspondence: <email>flavia.marinelli@uninsubria.it</email>; Tel.: +39-0332-42-1546</corresp></author-notes><pub-date pub-type="epub"><day>11</day><month>12</month><year>2022</year></pub-date><pub-date pub-type="collection"><month>12</month><year>2022</year></pub-date><volume>23</volume><issue>24</issue><elocation-id>15713</elocation-id><history><date date-type="received"><day>07</day><month>11</month><year>2022</year></date><date date-type="accepted"><day>06</day><month>12</month><year>2022</year></date></history><permissions><copyright-statement>&#x000a9; 2022 by the authors.</copyright-statement><copyright-year>2022</copyright-year><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><abstract><p>Glycopeptide antibiotics (GPAs) are among the most clinically successful antimicrobials. GPAs inhibit cell-wall biosynthesis in Gram-positive bacteria via binding to lipid II. Natural GPAs are produced by various actinobacteria. Being themselves Gram-positives, the GPA producers evolved sophisticated mechanisms of self-resistance to avoid suicide during antibiotic production. These self-resistance genes are considered the primary source of GPA resistance genes actually spreading among pathogenic enterococci and staphylococci. The GPA-resistance mechanism in <italic toggle="yes">Actinoplanes teichomyceticus</italic>&#x02014;the producer of the last-resort-drug teicoplanin&#x02014;has been intensively studied in recent years, posing relevant questions about the role of Tei3 sensor histidine kinase. In the current work, the molecular properties of Tei3 were investigated. The setup of a GPA-responsive assay system in the model <italic toggle="yes">Streptomyces coelicolor</italic> allowed us to demonstrate that Tei3 functions as a non-inducible kinase, conferring high levels of GPA resistance in <italic toggle="yes">A.&#x000a0;teichomyceticus</italic>. The expression of different truncated versions of <italic toggle="yes">tei3</italic> in <italic toggle="yes">S.&#x000a0;coelicolor</italic> indicated that both the transmembrane helices of Tei3 are crucial for proper functioning. Finally, a hybrid gene was constructed, coding for a chimera protein combining the Tei3 sensor domain with the kinase domain of VanS, with the latter being the inducible Tei3 ortholog from <italic toggle="yes">S. coelicolor.</italic> Surprisingly, such a chimera did not respond to teicoplanin, but indeed to the related GPA A40926. Coupling these experimental results with a further in silico analysis, a novel scenario on GPA-resistance and biosynthetic genes co-evolution in <italic toggle="yes">A.&#x000a0;teichomyceticus</italic> was hereby proposed.</p></abstract><kwd-group><kwd><italic toggle="yes">Actinoplanes teichomyceticus</italic></kwd><kwd>VanS</kwd><kwd>glycopeptide antibiotic resistance</kwd><kwd>teicoplanin</kwd><kwd>A40926</kwd></kwd-group><funding-group><award-group><funding-source>Fondo di Ateneo per la Ricerca</funding-source></award-group><award-group><funding-source>Ministry of Education and Science of Ukraine</funding-source><award-id>BG-09F</award-id></award-group><funding-statement>This work was supported by the public grant &#x0201c;Fondo di Ateneo per la Ricerca&#x0201d; 2020 and 2021 to F.M., and by the BG-09F grant of the Ministry of Education and Science of Ukraine to V.F.</funding-statement></funding-group></article-meta></front><body><sec sec-type="intro" id="sec1-ijms-23-15713"><title>1. Introduction</title><p>Glycopeptide antibiotics (GPAs) [<xref rid="B1-ijms-23-15713" ref-type="bibr">1</xref>], particularly dalbaheptides [<xref rid="B2-ijms-23-15713" ref-type="bibr">2</xref>], belong to a clinically relevant group of natural compounds produced by soil-dwelling and mycelium-forming Gram-positive actinobacteria, traditionally named actinomycetes [<xref rid="B3-ijms-23-15713" ref-type="bibr">3</xref>,<xref rid="B4-ijms-23-15713" ref-type="bibr">4</xref>]. As with other natural compounds, genes responsible for the biosynthesis of GPAs are grouped in large biosynthetic gene clusters (BGCs) [<xref rid="B5-ijms-23-15713" ref-type="bibr">5</xref>]. GPAs are successfully utilized to treat severe infections caused by multi-drug-resistant (MDR) staphylococcal and enterococcal strains. Two natural and three semisynthetic GPAs are currently approved for clinical use [<xref rid="B3-ijms-23-15713" ref-type="bibr">3</xref>,<xref rid="B6-ijms-23-15713" ref-type="bibr">6</xref>,<xref rid="B7-ijms-23-15713" ref-type="bibr">7</xref>]. Natural first-generation GPAs are vancomycin and teicoplanin, produced by the actinobacteria <italic toggle="yes">Amycolatopsis orientalis</italic> (various strains) [<xref rid="B8-ijms-23-15713" ref-type="bibr">8</xref>] and <italic toggle="yes">Actinoplanes teichomyceticus</italic> ATCC 31121 [<xref rid="B9-ijms-23-15713" ref-type="bibr">9</xref>], respectively. Vancomycin was introduced in clinics first (in 1958), followed by teicoplanin (1988) in Europe and then in Japan (1998) [<xref rid="B3-ijms-23-15713" ref-type="bibr">3</xref>]. Semisynthetic second-generation GPAs include telavancin&#x02014;a vancomycin derivative [<xref rid="B10-ijms-23-15713" ref-type="bibr">10</xref>], oritavancin&#x02014;a derivative of the natural GPA chloroeremomycin [<xref rid="B11-ijms-23-15713" ref-type="bibr">11</xref>], and dalbavancin&#x02014;a derivative of the other natural GPA, A40926 [<xref rid="B12-ijms-23-15713" ref-type="bibr">12</xref>].</p><p>Although GPAs of both generations are still clinically useful, resistant pathogens are inevitably emerging [<xref rid="B13-ijms-23-15713" ref-type="bibr">13</xref>,<xref rid="B14-ijms-23-15713" ref-type="bibr">14</xref>,<xref rid="B15-ijms-23-15713" ref-type="bibr">15</xref>,<xref rid="B16-ijms-23-15713" ref-type="bibr">16</xref>]. Peculiarly, resistance mechanisms in GPA producers and pathogens are very similar [<xref rid="B17-ijms-23-15713" ref-type="bibr">17</xref>]. It is likely that pathogens acquired GPA resistance genes from GPA producers, or more generally from non-producing actinobacteria, where GPA resistance determinants are abundant [<xref rid="B18-ijms-23-15713" ref-type="bibr">18</xref>,<xref rid="B19-ijms-23-15713" ref-type="bibr">19</xref>]. GPAs interact with <sc>d-</sc>alanyl-<sc>d-</sc>alanine (<sc>d-</sc>Ala-<sc>d-</sc>Ala) termini of the nascent peptidoglycan (PG), impeding upstream transpeptidation and transglycosylation reactions and consequently blocking cell wall biosynthesis [<xref rid="B20-ijms-23-15713" ref-type="bibr">20</xref>]. The resistance mechanisms shared between GPA producers and pathogens lead to the modification of the <sc>d-</sc>Ala-<sc>d-</sc>Ala termini, reducing the affinity of GPAs for their target. <sc>d-A</sc>la-<sc>d-</sc>Ala termini in PG precursors are replaced by <sc>d-A</sc>la-<sc>d-</sc>lactate (<sc>d-</sc>Lac) [<xref rid="B17-ijms-23-15713" ref-type="bibr">17</xref>,<xref rid="B21-ijms-23-15713" ref-type="bibr">21</xref>] or truncated to a single <sc>d-A</sc>la residue [<xref rid="B22-ijms-23-15713" ref-type="bibr">22</xref>,<xref rid="B23-ijms-23-15713" ref-type="bibr">23</xref>,<xref rid="B24-ijms-23-15713" ref-type="bibr">24</xref>]. The first mechanism requires a three-gene operon&#x02014;<italic toggle="yes">vanHAX,</italic> where <italic toggle="yes">vanH</italic> codes for a <sc>d-</sc>Lac dehydrogenase responsible for generating a <sc>d-</sc>Lac pool, <italic toggle="yes">vanX</italic>&#x02014;for a <sc>d</sc>,<sc>d</sc>-dipeptidase whose role is reducing the intracellular pool of <sc>d</sc>-Ala-<sc>d</sc>-Ala [<xref rid="B25-ijms-23-15713" ref-type="bibr">25</xref>,<xref rid="B26-ijms-23-15713" ref-type="bibr">26</xref>], and <italic toggle="yes">vanA</italic>&#x02014;for a <sc>d-</sc>Ala-<sc>d-</sc>Lac ligase [<xref rid="B21-ijms-23-15713" ref-type="bibr">21</xref>,<xref rid="B27-ijms-23-15713" ref-type="bibr">27</xref>]. The second involves a single <sc>d</sc>,<sc>d</sc>-carboxypeptidase named VanY, which trims the terminal <sc>d</sc>-Ala residue. In both cases, PG precursors still undergo transpeptidation reactions, but this process is not affected by GPAs [<xref rid="B22-ijms-23-15713" ref-type="bibr">22</xref>,<xref rid="B23-ijms-23-15713" ref-type="bibr">23</xref>,<xref rid="B24-ijms-23-15713" ref-type="bibr">24</xref>]. The expression of <italic toggle="yes">vanY</italic> or <italic toggle="yes">vanHAX</italic> might be constitutive or inducible. The latter requires a two-component regulatory system consisting of a sensor histidine kinase (SHK) and a transcriptional response regulator (RR), also known as VanS and VanR, respectively [<xref rid="B28-ijms-23-15713" ref-type="bibr">28</xref>,<xref rid="B29-ijms-23-15713" ref-type="bibr">29</xref>,<xref rid="B30-ijms-23-15713" ref-type="bibr">30</xref>,<xref rid="B31-ijms-23-15713" ref-type="bibr">31</xref>]. VanS can specifically recognize extracellular GPAs and phosphorylate VanR, which, in turn, activates the expression of other <italic toggle="yes">van</italic> genes [<xref rid="B29-ijms-23-15713" ref-type="bibr">29</xref>,<xref rid="B30-ijms-23-15713" ref-type="bibr">30</xref>,<xref rid="B31-ijms-23-15713" ref-type="bibr">31</xref>,<xref rid="B32-ijms-23-15713" ref-type="bibr">32</xref>,<xref rid="B33-ijms-23-15713" ref-type="bibr">33</xref>].</p><p>Actinobacterial GPA producers such as <italic toggle="yes">A. teichomyceticus, Amycolatopsis balhimycina</italic> DSM 5908 (balhimycin producer), <italic toggle="yes">Nonomuraea gerenzanensis</italic> ATCC 39727 (A40926 producer), <italic toggle="yes">Streptomyces toyocaensis</italic> NRRL 15009 (A47934 producer), as well as the GPA non-producing <italic toggle="yes">Streptomyces coelicolor</italic> A3(2) represent well-studied models of GPA resistance mechanisms (recently reviewed in [<xref rid="B34-ijms-23-15713" ref-type="bibr">34</xref>]), although certain aspects are not fully elucidated yet and merit further investigation. In this work, the properties of Tei3&#x02014;the VanS ortholog from the teicoplanin producer <italic toggle="yes">A. teichomyceticus</italic>&#x02014;were investigated in vivo. Notably, <italic toggle="yes">A. teichomyceticus</italic> is resistant to very high concentrations of teicoplanin, likely due to the strong constitutive expression of the <italic toggle="yes">vanHAX</italic> orthologs&#x02014;<italic toggle="yes">tei7-6-5</italic>, which was previously reported during the transcription analyses of the <italic toggle="yes">tei</italic> BGC [<xref rid="B35-ijms-23-15713" ref-type="bibr">35</xref>,<xref rid="B36-ijms-23-15713" ref-type="bibr">36</xref>,<xref rid="B37-ijms-23-15713" ref-type="bibr">37</xref>]. It was speculated that Tei3 acts as a constitutive SHK [<xref rid="B35-ijms-23-15713" ref-type="bibr">35</xref>]. We aimed to experimentally investigate whether Tei3 really acts as a constitutive SHK and if any GPA is eventually recognized by its sensor domain (SD). Conducting a series of experiments in <italic toggle="yes">S. coelicolor</italic> as a heterologous host, it was found out that Tei3 does not require any ligand to function. Strikingly, the SD of Tei3 appeared to recognize not teicoplanin but the structurally related GPA A40926. Finally, reconstruction of the phylogeny of glycosyltransferases (GTFs) coded within GPA BGCs allowed us to build a possible scenario explaining the obtained results.</p></sec><sec sec-type="results" id="sec2-ijms-23-15713"><title>2. Results</title><p>The main goals of this work were to test if Tei3 acts as a non-inducible phosphorylase and to investigate which ligand could be sensed by Tei3. Considering <italic toggle="yes">A. teichomyceticus</italic> a challenging microorganism for gene-engineering manipulations, a series of genetic experiments were designed and performed in heterologous hosts such as <italic toggle="yes">S. coelicolor</italic> M512 [<xref rid="B38-ijms-23-15713" ref-type="bibr">38</xref>] and <italic toggle="yes">S. coelicolor</italic> J3200 [<xref rid="B31-ijms-23-15713" ref-type="bibr">31</xref>]. As anticipated in the introduction, <italic toggle="yes">S. coelicolor</italic> has a full set of <italic toggle="yes">van</italic> genes conferring vancomycin resistance, although it does not produce any GPAs [<xref rid="B39-ijms-23-15713" ref-type="bibr">39</xref>]. <italic toggle="yes">S. coelicolor</italic> M512 does not produce the pigmented antibiotics actinorhodin and undecylprodigiosin [<xref rid="B38-ijms-23-15713" ref-type="bibr">38</xref>], permitting the use of a &#x003b2;-glucuronidase (GusA)-based reporter assay, as described below. The second strain&#x02014;J3200&#x02014;is the &#x00394;<italic toggle="yes">vanS<sub>Sc</sub></italic> mutant, in which the host <italic toggle="yes">vanS</italic> gene was knocked out [<xref rid="B31-ijms-23-15713" ref-type="bibr">31</xref>]. Thus, the experimental steps described below aimed: (1) to test if the heterologous Tei3 can cross-phosphorylate the host VanR<sub>Sc</sub>; (2) to build a <italic toggle="yes">gusA</italic>-based reporter <italic toggle="yes">S. coelicolor</italic> strain, able to convert X-Gluc (5-bromo-4-chloro-3-indolyl-&#x003b2;-<sc>d-</sc>glucuronide) to 5,5&#x02032;-dibromo-4,4&#x02032;-dichloro-indigo following GPA induction; (3) to utilize the created reporter strain to show if Tei3 needs the presence of GPAs or not; (4) to replace the SD of the host VanS<sub>Sc</sub> with its counterpart from Tei3 and test which GPAs may act as ligands for Tei3 SD.</p><sec id="sec2dot1-ijms-23-15713"><title>2.1. Heterologous Expression of Tei3 SHK Leads to Teicoplanin and A40926 Resistance in S. coelicolor M512</title><p>VanRS-like two-component regulatory pairs are conserved enough among actinobacteria to show a certain degree of cross-talking [<xref rid="B33-ijms-23-15713" ref-type="bibr">33</xref>,<xref rid="B40-ijms-23-15713" ref-type="bibr">40</xref>]. For example, it was shown that VanR<sub>Sc</sub> (coming from <italic toggle="yes">S. coelicolor</italic>) could be phosphorylated in vivo by VanS<sub>St</sub> (from A47934 producer <italic toggle="yes">S. toyocaensis</italic>), but not vice versa, implying that VanR<sub>Sc</sub> is accessible for non-cognate SHKs [<xref rid="B33-ijms-23-15713" ref-type="bibr">33</xref>]. In this case, SHKs and RRs both came from <italic toggle="yes">Streptomyces</italic> spp. Instead, it was necessary to check if Tei3 SHK from <italic toggle="yes">A. teichomyceticus</italic> (order <italic toggle="yes">Micromonosporales</italic>) could phosphorylate VanR<sub>Sc</sub>. Overall, Tei2 and Tei3 share a high percentage of aa sequence identity with VanR<sub>Sc</sub> and VanS<sub>Sc</sub>: 91% and 67%, respectively. Tei3 and VanS<sub>Sc</sub> are collinear, sharing highly similar transmembrane helix (TMHs) regions and conserved putative autophosphorylation sites (<xref rid="ijms-23-15713-f001" ref-type="fig">Figure 1</xref>a). The most divergent region between Tei3 and VanS<sub>Sc</sub> is the extracytoplasmic sensory loop (ESL), implying that quite different ligands should be recognized by the two proteins (<xref rid="ijms-23-15713-f001" ref-type="fig">Figure 1</xref>a). At the same time, Tei2 and VanR<sub>Sc</sub> were almost identical (<xref rid="ijms-23-15713-f001" ref-type="fig">Figure 1</xref>b). Thus, it seems plausible that Tei3 would be able to phosphorylate VanR<sub>Sc</sub> in vivo.</p><p>To test if Tei3 can phosphorylate the non-cognate RR&#x02014;VanR<sub>Sc</sub>, <italic toggle="yes">tei3</italic> was cloned into the pSET152A vector, giving pGP101, and then transferred into <italic toggle="yes">S. coelicolor</italic> M512. The obtained recombinant strain&#x02014;<italic toggle="yes">S. coelicolor</italic> M101&#x02014;gained teicoplanin and A40926 resistance, in addition to the endogenous vancomycin resistance (<xref rid="ijms-23-15713-f002" ref-type="fig">Figure 2</xref>). Consequently, it could be concluded that Tei3 phosphorylates VanR<sub>Sc</sub> in vivo. However, this experiment did not clarify whether Tei3 acts as a constitutive phosphorylase, considering that teicoplanin and A40926 added to the plates could serve as its activators.</p></sec><sec id="sec2dot2-ijms-23-15713"><title>2.2. Tei3 Acts as a Non-Inducible Phosphorylase</title><p>Expression of <italic toggle="yes">tei2-3-4</italic> and <italic toggle="yes">tei7-6-5</italic> operons remains stable throughout the life cycle of <italic toggle="yes">A. teichomyceticus,</italic> independently from the teicoplanin concentration [<xref rid="B35-ijms-23-15713" ref-type="bibr">35</xref>,<xref rid="B37-ijms-23-15713" ref-type="bibr">37</xref>], pathway-specific regulation [<xref rid="B36-ijms-23-15713" ref-type="bibr">36</xref>], and growth phase [<xref rid="B37-ijms-23-15713" ref-type="bibr">37</xref>]. Previous papers speculated about the need of a strong constitutive promoter driving <italic toggle="yes">tei2-3-4</italic> expression [<xref rid="B37-ijms-23-15713" ref-type="bibr">37</xref>] or of the presence of specific mutations in Tei3 that might explain its function as a constitutive phosphorylase, working independently from the presence of any extracellular GPA [<xref rid="B35-ijms-23-15713" ref-type="bibr">35</xref>]. Protein sequence comparison indicated that Tei3 carries single aa substitutions in two sites where analogous mutations transform the vancomycin-inducible VanS<sub>Sc</sub> into a constitutive phosphorylase [<xref rid="B35-ijms-23-15713" ref-type="bibr">35</xref>]. Specifically, these are L216P and G271V substitutions [<xref rid="B31-ijms-23-15713" ref-type="bibr">31</xref>]. Homologous sites in Tei3 are N215 and R270 (<xref rid="ijms-23-15713-f001" ref-type="fig">Figure 1</xref>a). However, there are multiple other sites within the putative ATPase domain (ATPaseD) of Tei3, which significantly diverged from VanS<sub>Sc</sub> (see <xref rid="ijms-23-15713-f001" ref-type="fig">Figure 1</xref>a).</p><p>To experimentally verify the GPA inducibility of Tei3, a bioassay responding to the inducers of <italic toggle="yes">van</italic> genes was first developed in <italic toggle="yes">S. coelicolor</italic>. Other authors previously described a reporter <italic toggle="yes">S. coelicolor</italic> strain, where the endogenous <italic toggle="yes">vanJ</italic> promoter (<italic toggle="yes">vanJp</italic>) was cloned into a multicopy plasmid, fused with the kanamycin/neomycin resistance gene&#x02014;<italic toggle="yes">neo</italic>&#x02014;in a way that induction of <italic toggle="yes">vanJp</italic> by vancomycin conferred resistance to both neomycin and kanamycin [<xref rid="B39-ijms-23-15713" ref-type="bibr">39</xref>]. Using this experience, either <italic toggle="yes">vanJp</italic> or the other endogenous vancomycin-responsive <italic toggle="yes">S. coelicolor vanHAX</italic> promoter (<italic toggle="yes">vanHp</italic>) was fused with the <italic toggle="yes">gusA</italic> gene, coding for a &#x003b2;-glucuronidase in the pGUS chassis [<xref rid="B44-ijms-23-15713" ref-type="bibr">44</xref>]. <italic toggle="yes">vanJp</italic> or <italic toggle="yes">vanHp</italic> activation by GPAs in the reporter strain should activate the chromogenic conversion of the X-Gluc substrate into the green-colored 5,5&#x02032;-dibromo-4,4&#x02032;-dichloro-indigo [<xref rid="B44-ijms-23-15713" ref-type="bibr">44</xref>]. Thus, plasmids pGHp (carrying <italic toggle="yes">vanHp-gusA</italic>) and pGJp (carrying <italic toggle="yes">vanJp-gusA</italic>) were transferred to <italic toggle="yes">S. coelicolor</italic> M512 by means of intergeneric conjugation with <italic toggle="yes">Escherichia coli</italic> ET12567 pUZ8002<sup>+</sup>. The inducibility of the two generated reporter strains <italic toggle="yes">S. coelicolor</italic> pGHp<sup>+</sup> and pGJp<sup>+</sup> was first tested in liquid medium and then in solid plates. When vancomycin was added at 10 &#x000b5;g/mL to 50 h old cultures in TSB liquid medium, the basal glucuronidase activity of the mycelia was increased by, ca., twenty- and forty-fold, in <italic toggle="yes">S. coelicolor</italic> pGHp<sup>+</sup> and pGJp<sup>+</sup>, respectively (<xref rid="app1-ijms-23-15713" ref-type="app">Figure S1</xref>), indicating that <italic toggle="yes">vanJp</italic> seems more responsive to vancomycin than <italic toggle="yes">vanHp.</italic> In solid media containing 25 &#x000b5;g/mL of X-Gluc, the presence of vancomycin induced <italic toggle="yes">vanJp</italic>-mediated glucuronidase activity in recombinant strains, yielding green halos around the Whatman discs soaked in antibiotic solution (<xref rid="ijms-23-15713-f003" ref-type="fig">Figure 3</xref> and <xref rid="app1-ijms-23-15713" ref-type="app">Figure S2</xref>). <italic toggle="yes">S. coelicolor</italic> pGJp<sup>+</sup> acted very well as a reporter, giving a detectable chromogenic conversion in response to very low concentrations of vancomycin (250 ng, <xref rid="app1-ijms-23-15713" ref-type="app">Figure S2</xref>), whereas <italic toggle="yes">S. coelicolor</italic> pGHp<sup>+</sup> resulted as much less responsive to vancomycin (data not shown) and, thus, it was not further used.</p><p>The next step was transferring Tei3 into <italic toggle="yes">S. coelicolor</italic> pGJp<sup>+</sup> to test if its activity is inducible by GPAs. As either pGJp or pGP101 is a distant derivative of pSET152 [<xref rid="B45-ijms-23-15713" ref-type="bibr">45</xref>], both plasmids use the &#x003c6;C31 <italic toggle="yes">attB</italic> site for integration and are not compatible. To solve this issue, the pRT801 plasmid [<xref rid="B46-ijms-23-15713" ref-type="bibr">46</xref>] was used to create a &#x003c6;BT1-based derivative of pGP101, named pGP111. The M512 derivative carrying pGP111 (carrying <italic toggle="yes">tei3</italic>) was named M111, while the strain carrying both pGP111 and pGJp was named M1J. It was expected that if Tei3 functions as a constitutive phosphorylase, M1J would express a constitutive glucuronidase activity in the presence of X-Gluc, not depending on the presence or absence of GPAs. This assumption was correct as M1J converted X-Gluc independently from the presence of any GPA (<xref rid="ijms-23-15713-f003" ref-type="fig">Figure 3</xref>), confirming in vivo that Tei3 functions as a constitutive phosphorylase. As a control, it was shown that no induction was observed in those strains not carrying <italic toggle="yes">vanJp-gusA</italic> (M512 and M111), whereas the GPA induction was observed in <italic toggle="yes">S. coelicolor</italic> pGJp<sup>+</sup> due to the action of the endogenous VanS<sub>Sc</sub>.</p></sec><sec id="sec2dot3-ijms-23-15713"><title>2.3. Loss of Extracytoplasmic Sensory Loop and Transmembrane Helices Renders Tei3 and VanS<sub>Sc</sub> Nonfunctional</title><p>Considering the non-inducible properties of Tei3, we were wondering whether TMHs and ESL are still necessary for its function, or whether ATPaseD would be the only required domain. To answer this question, a series of plasmids was created carrying truncated versions of <italic toggle="yes">tei3</italic> or of <italic toggle="yes">vanS<sub>Sc</sub></italic> lacking (i) TMH1 and ESL (<italic toggle="yes">tei3</italic>&#x02032;, <italic toggle="yes">vanS<sub>Sc</sub></italic>&#x02032;); (ii) TMH1, ESL, and TMH2 (<italic toggle="yes">tei3</italic>&#x02033;, <italic toggle="yes">vanS<sub>Sc</sub></italic>&#x02033;) (<xref rid="app1-ijms-23-15713" ref-type="app">Figure S3</xref>). These plasmids were named pGP104 (<italic toggle="yes">tei3</italic>&#x02032;), pGP105 (<italic toggle="yes">vanS<sub>Sc</sub></italic>&#x02032;), pGP106 (<italic toggle="yes">tei3</italic>&#x02033;), and pGP107 (<italic toggle="yes">vanS<sub>Sc</sub></italic>&#x02033;). Plasmids were transferred into <italic toggle="yes">S. coelicolor</italic> M512 (resistant to vancomycin but sensitive to teicoplanin and A40926) and <italic toggle="yes">S. coelicolor</italic> J3200 (this last one&#x02014;&#x00394;<italic toggle="yes">vanS<sub>Sc</sub></italic>&#x02014;is constitutively resistant to all GPAs), generating M104-107 and J104-107 strains. It was expected that if ATPaseD of Tei3 would be able to function alone, the expression of <italic toggle="yes">tei3</italic>&#x02032; and <italic toggle="yes">tei3</italic>&#x02033; might lead to constitutive GPA resistance in M512. On the contrary, the absence of the SD in VanS<sub>Sc</sub> might render J3200 constitutively sensitive to GPAs. However, the obtained results indicated that ATPaseDs of neither Tei3 nor VanS<sub>Sc</sub> can function alone: the phenotypes of M104-107 and J104-107 strains in the presence of vancomycin, teicoplanin, and A40926 were the same as the parental M512 and J3200 strains, respectively (<xref rid="ijms-23-15713-f004" ref-type="fig">Figure 4</xref>).</p></sec><sec id="sec2dot4-ijms-23-15713"><title>2.4. Tei3 Sensor Domain Is Sensitive to A40926 but Not to Teicoplanin and Vancomycin</title><p>Logically, teicoplanin should be the original ligand for Tei3. However, direct experimental verification of this assumption is impossible due to the non-inducible properties of Tei3. It is possible that maybe Tei3 became a constitutive phosphorylase in the course of the evolution, but clues for Tei3 sensitivity might have remained &#x0201c;fossilized&#x0201d; within its SD. To answer this question, a hybrid gene coding for a chimeric SHK combining the SD of Tei3 with the ATPaseD of VanS<sub>Sc</sub> was created. <italic toggle="yes">vanS<sub>Sc</sub></italic> and <italic toggle="yes">tei3</italic> (<xref rid="app1-ijms-23-15713" ref-type="app">Figure S4</xref>) were collinear, facilitating such an exchange. Luckily, a unique <italic toggle="yes">Pae</italic>I recognition site was found only 4 bp after the <italic toggle="yes">vanS<sub>Sc</sub></italic> region coding for SD. This allowed us to use this site for replacing the <italic toggle="yes">vanS<sub>Sc</sub></italic> region coding for the SD with the corresponding one from <italic toggle="yes">tei3</italic> (see <xref rid="sec4-ijms-23-15713" ref-type="sec">Section 4</xref> for details). The obtained hybrid gene&#x02014;<italic toggle="yes">tei3-vanS<sub>Sc</sub></italic> (<xref rid="app1-ijms-23-15713" ref-type="app">Figure S4</xref>)&#x02014;was cloned into the pSET152A plasmid generating pGP103. Next, pGP103 was transferred into M512 and J3200 generating the recombinant strains M103 and J103, respectively. In the first case, a merodiploid strain was generated, carrying the native <italic toggle="yes">vanS<sub>Sc</sub></italic> together with the hybrid <italic toggle="yes">tei3-vanS<sub>Sc</sub></italic> allele, while in J3200, the knockout of <italic toggle="yes">vanS<sub>Sc</sub></italic> was complemented by the added <italic toggle="yes">tei3-vanS<sub>Sc</sub></italic>. GPA resistance phenotypes of these recombinants showed that both M103 and J103 became sensitive to vancomycin, implying that this GPA is not an inducer for the Tei3 SD (<xref rid="ijms-23-15713-f005" ref-type="fig">Figure 5</xref>).</p><p>Surprisingly, M103 and J103 were also sensitive to teicoplanin, excluding its possible role as a ligand for the Tei3 SD. Adding a final detail to these puzzling results, both M103 and J103 were resistant to A40926, implying that the Tei3 SD recognizes A40926 as a ligand.</p></sec><sec id="sec2dot5-ijms-23-15713"><title>2.5. Establishing a Link between the Evolution of Glycosylation Pattern of Teicoplanin and Properties of Tei3 SD</title><p>Teicoplanin and A40926 are chemically similar GPAs that likely emerged in the course of convergent evolution (<xref rid="app1-ijms-23-15713" ref-type="app">Figure S5</xref>) [<xref rid="B47-ijms-23-15713" ref-type="bibr">47</xref>,<xref rid="B48-ijms-23-15713" ref-type="bibr">48</xref>,<xref rid="B49-ijms-23-15713" ref-type="bibr">49</xref>]. Differences lie in the chlorination and methylation pattern; notably, A40926 also lacks a <italic toggle="yes">N</italic>-acetyl glucosamine (Glc<italic toggle="yes">N</italic>Ac) moiety attached to the aglycone of teicoplanin at the aa position 6 (AA6) (<xref rid="app1-ijms-23-15713" ref-type="app">Figure S5</xref>). The glycosylation pattern might be important for binding VanS, in accordance with previous results reporting that VanS from <italic toggle="yes">S. toyocaensis</italic> was unable to recognize vancomycin, sensing only the non-glycosylated A47934 [<xref rid="B33-ijms-23-15713" ref-type="bibr">33</xref>]. Hence, it could be speculated that the responsiveness of Tei3 to a GPA lacking a Glc<italic toggle="yes">N</italic>Ac residue might be an ancient property from the times when the ancestral teicoplanin BGC did not carry a gene for the attachment of the Glc<italic toggle="yes">N</italic>Ac moiety at aglycone AA6. To understand this better, the phylogeny of glycosyl transferases (GTFs) coming from experimentally studied GPA BGCs was reconstructed (<xref rid="ijms-23-15713-f006" ref-type="fig">Figure 6</xref>).</p><p>Five clades (A&#x02013;D) might be delineated on the obtained tree (<xref rid="ijms-23-15713-f006" ref-type="fig">Figure 6</xref>) and they seem to correspond to the regiospecificity of GTFs well. The regiospecificity of clades (A&#x02013;C) GTFs could be predicted with high confidence as, for many members of these clades, experimental evidence exists. Thus, clade (A) comprehended GTFs attaching either <sc>d</sc>-glucose or Glc<italic toggle="yes">N</italic>Ac to AA4 of the GPA aglycone (see [<xref rid="B50-ijms-23-15713" ref-type="bibr">50</xref>] for the review of such GTFs); clade (B) GTFs are responsible for the attachment of <sc>l</sc>-aminosugars to AA4 <sc>d</sc>-glucose [<xref rid="B50-ijms-23-15713" ref-type="bibr">50</xref>]; clade (C) included GTFs from ristocetin BGCs likely attaching <sc>d</sc>-arabinose to AA4 <sc>d</sc>-mannosyl-<sc>d</sc>-glucose [<xref rid="B51-ijms-23-15713" ref-type="bibr">51</xref>] (<xref rid="ijms-23-15713-f006" ref-type="fig">Figure 6</xref>). The substrate- and regiospecificity of GTFs from clades (D) and (E) were dubious: clade (D) GTFs probably attach <sc>l</sc>-rhamnose to the AA4 <sc>d</sc>-glucose, while clade (E) GTFs may attach <sc>l</sc>-aminosugars to aglycone AA6. To our surprise, Tei1&#x02014;known to attach the Glc<italic toggle="yes">N</italic>Ac moiety at the teicoplanin aglycone AA6 [<xref rid="B52-ijms-23-15713" ref-type="bibr">52</xref>]&#x02014;was found deep in clade (A), being a sister branch to Tei10* (known to attach Glc<italic toggle="yes">N</italic>Ac at AA4). One other GPA&#x02014;GP1416 from <italic toggle="yes">Amycolatopsis</italic> sp. WAC01416 [<xref rid="B53-ijms-23-15713" ref-type="bibr">53</xref>]&#x02014;is known to closely resemble the teicoplanin structure, bearing the Glc<italic toggle="yes">N</italic>Ac moiety at AA6. However, the GTF that is likely responsible for this did not belong to any of the clades and was located far from either Tei1 or Tei10* (<xref rid="ijms-23-15713-f006" ref-type="fig">Figure 6</xref>). The presence of the Glc<italic toggle="yes">N</italic>Ac moiety at AA6 of teicoplanin and GP1416 could, thus, be considered an example of the convergent evolution of GPAs. Considering all mentioned above, one could reasonably assume that Tei1 is a recent product of the Tei10* duplication/divergence event. In the course of evolution, it is likely that Tei1 changed its regiospecificity but retained the substrate specificity. A direct ancestor of teicoplanin BGC likely coded the biosynthesis of des-Glc<italic toggle="yes">N</italic>Ac-teicoplanin, which structurally resembles A40926 and was recognized by the Tei3 SD (see <xref rid="ijms-23-15713-f007" ref-type="fig">Figure 7</xref> and the discussion below for a possible reconstruction of co-evolution of GTFs encoded in teicoplanin BGC and Tei3).</p></sec></sec><sec sec-type="discussion" id="sec3-ijms-23-15713"><title>3. Discussion</title><p><italic toggle="yes">vanHAXRS</italic> genes were experimentally shown to provide GPA resistance in (i) GPA-producing actinobacteria [<xref rid="B34-ijms-23-15713" ref-type="bibr">34</xref>], (ii) actinobacterial GPA non-producers [<xref rid="B31-ijms-23-15713" ref-type="bibr">31</xref>], (iii) GPA-resistant pathogens [<xref rid="B28-ijms-23-15713" ref-type="bibr">28</xref>], and (iv) other soil bacteria [<xref rid="B19-ijms-23-15713" ref-type="bibr">19</xref>,<xref rid="B54-ijms-23-15713" ref-type="bibr">54</xref>]. In the majority of the known cases, the VanRS two-component regulatory system is utilized to sense extracellular GPAs [<xref rid="B29-ijms-23-15713" ref-type="bibr">29</xref>] (or perhaps the GPA-lipid II complex [<xref rid="B30-ijms-23-15713" ref-type="bibr">30</xref>]) and activate the expression of functional <italic toggle="yes">van</italic> genes. Pathogens and GPA-non-producing actinobacteria generally have inducible <italic toggle="yes">van</italic>-resistant phenotypes, because the constitutive expression of <italic toggle="yes">van</italic> genes comes at a cost of decreased fitness of the cells [<xref rid="B55-ijms-23-15713" ref-type="bibr">55</xref>,<xref rid="B56-ijms-23-15713" ref-type="bibr">56</xref>].</p><fig position="anchor" id="ijms-23-15713-f006"><label>Figure 6</label><caption><p>Maximum-likelihood phylogenetic tree of 59 GTFs coded within or near experimentally studied GPA BGCs and NovM from clorobiocin BGC [<xref rid="B57-ijms-23-15713" ref-type="bibr">57</xref>], used as an outgroup (the tree is not drawn to scale). MEGA 11 was used for the analysis [<xref rid="B58-ijms-23-15713" ref-type="bibr">58</xref>]. Evolution was inferred by using the JTT matrix-based model [<xref rid="B59-ijms-23-15713" ref-type="bibr">59</xref>]. A discrete &#x003b3; distribution was used to model evolutionary rate differences among sites (5 categories). Numbers at nodes indicate bootstrap-support values derived from 1000 replications. Five clades were delineated on this tree (<bold>A</bold>&#x02013;<bold>E</bold>); clades correlated with substrate- and regiospecificity of GTFs. Veg36-OLZ52430-AIG79202 seemed to be a clade of few additional irrelevant GTFs coded nearby the corresponding BGCs. Notably, Tei1 (marked with &#x0201c;Glc<italic toggle="yes">N</italic>Ac-AA6 (!)&#x0201d; label) appeared in the clade (<bold>A</bold>) grouping GTFs attaching either <sc>d-</sc>glucose or Glc<italic toggle="yes">N</italic>Ac to aglycone AA4, while the enzyme was experimentally shown to attach Glc<italic toggle="yes">N</italic>Ac to aglycone AA6. &#x0201c;(?)&#x0201d; signs indicate presumed regiospecificity (lack of experimental evidence).</p></caption><graphic xlink:href="ijms-23-15713-g006" position="float"/></fig><p>In contrast, the GPA resistance phenotype is commonly constitutive in GPA producers, as it was shown in <italic toggle="yes">A. teichomyceticus</italic> and <italic toggle="yes">Am. balhimycina</italic> [<xref rid="B34-ijms-23-15713" ref-type="bibr">34</xref>]. In <italic toggle="yes">Am. balhimycina</italic>, <italic toggle="yes">vanHAX</italic> orthologs are the main contributors to GPA resistance [<xref rid="B40-ijms-23-15713" ref-type="bibr">40</xref>,<xref rid="B60-ijms-23-15713" ref-type="bibr">60</xref>]. However, <italic toggle="yes">vanHAX</italic> are not situated within the borders of balhimycin BGC (as commonly occurs in the other actinomycetes producing GPAs), and they are not co-localized with <italic toggle="yes">vanRS</italic> orthologs [<xref rid="B40-ijms-23-15713" ref-type="bibr">40</xref>]. Hence, the expression of <italic toggle="yes">vanHAX</italic> is devoid of <italic toggle="yes">vanRS</italic>-mediated regulation and is constitutive. It should be noted that <italic toggle="yes">Am. balhimycina</italic> also possesses additional GPA-resistance mechanisms that are not <italic toggle="yes">van</italic>-mediated [<xref rid="B61-ijms-23-15713" ref-type="bibr">61</xref>].</p><fig position="float" id="ijms-23-15713-f007"><label>Figure 7</label><caption><p>A scheme illustrating possible scenarios for the co-evolution of GTFs encoded in teicoplanin BGC and Tei3. Please refer to the main text for more detail.</p></caption><graphic xlink:href="ijms-23-15713-g007" position="float"/></fig><p>The most striking outcome of our work was that the SD of Tei3 did not respond to teicoplanin, but recognized A40926: the expression of the hybrid SHK carrying the Tei3 SD fused with the catalytic part from VanS<sub>Sc</sub> changed the constitutive GPA-resistance phenotype of <italic toggle="yes">S. coelicolor</italic> J3200, making the strain teicoplanin- and vancomycin-sensitive, but A40926-resistant. This prompted us to focus on the chemical differences in the structure of A40926 and teicoplanin (the presence of a Glc<italic toggle="yes">N</italic>Ac residue in teicoplanin, which is absent in A40296) and on the possible evolution of the teicoplanin glycosylation pattern and of the whole <italic toggle="yes">tei</italic> BGC. Reconstruction of the phylogeny of GTFs coded within the known GPA BGCs allowed us to build possible scenarios explaining the obtained results (<xref rid="ijms-23-15713-f007" ref-type="fig">Figure 7</xref>).</p><p>If our reconstruction of the evolution of Tei1/Tei10* is correct, the ancestor of the teicoplanin BGC coded the biosynthesis of des-Glc<italic toggle="yes">N</italic>Ac-teicoplanin, which structurally resembles A40926 and was recognized by the Tei3 SD. Tei3 SHK initially responded to des-Glc<italic toggle="yes">N</italic>Ac-teicoplanin (modeled with A40926 in the experiment presented in this work) (<xref rid="ijms-23-15713-f007" ref-type="fig">Figure 7</xref>) and it was probably inducible. A further two alternative scenarios are possible. The first implies that the non-inducibility of Tei3 evolved as an adaptation to the appearance of Tei1 because <italic toggle="yes">A. teichomyceticus</italic> was required to rapidly gain constitutive GPA resistance as Tei3 was unable to sense teicoplanin. The second scenario implies that Tei3 in the des-Glc<italic toggle="yes">N</italic>Ac-teicoplanin producer became non-inducible at the first place, consequently giving the BGC room for further evolution and structural changes of the produced GPA. Considering that, in the first hypothesis, fewer mutations would probably be required to give Tei3 constitutive properties than to remodel its SD, the second scenario is more likely in our opinion. Hence, mutations leading to the non-inducibility of Tei3 might have served as a preadaptation, which allowed teicoplanin to emerge in its current form, carrying the Glc<italic toggle="yes">N</italic>Ac residue at AA6 (<xref rid="ijms-23-15713-f007" ref-type="fig">Figure 7</xref>).</p><p>To conclude, our results proved the non-inducibility of Tei3, showed that its SD is able to respond to A40926, but not to teicoplanin or vancomycin, and demonstrated a novel example of how BGCs, antibiotic structures, and antibiotic resistance genes might have co-evolved. Further investigations will include mutational analysis of Tei3 to elucidate which particular aa changes in its ATPaseD lead to non-inducible properties. Finally, as a byproduct, a <italic toggle="yes">S. coelicolor</italic>-based chromogenic assay for vancomycin detection was developed capable of sensing vancomycin at the ng range.</p></sec><sec id="sec4-ijms-23-15713"><title>4. Materials and Methods</title><sec id="sec4dot1-ijms-23-15713"><title>4.1. Plasmids, Bacterial Strains, and Cultivation Conditions</title><p>All plasmids and bacterial strains utilized or generated in the course of the current study are summarized in <xref rid="ijms-23-15713-t001" ref-type="table">Table 1</xref>. For routine maintenance, <italic toggle="yes">A. teichomyceticus</italic> was cultivated on ISP3 agar [<xref rid="B62-ijms-23-15713" ref-type="bibr">62</xref>] at 30 &#x000b0;C, and <italic toggle="yes">S. coelicolor</italic> strains were cultivated on SFM [<xref rid="B45-ijms-23-15713" ref-type="bibr">45</xref>] agar at 30 &#x000b0;C. For genomic DNA isolation, <italic toggle="yes">A. teichomyceticus</italic> was cultivated in ISP2 liquid medium [<xref rid="B47-ijms-23-15713" ref-type="bibr">47</xref>] in 50 mL baffled flasks on an orbital shaker at 200 rpm and 30 &#x000b0;C; <italic toggle="yes">S. coelicolor</italic> strains for genomic DNA isolation were cultivated under the same conditions in TSB medium [<xref rid="B62-ijms-23-15713" ref-type="bibr">62</xref>]. Antibiotic susceptibility tests with <italic toggle="yes">S. coelicolor</italic> strains were performed on SMMS medium [<xref rid="B45-ijms-23-15713" ref-type="bibr">45</xref>]. Apramycin sulfate (50 &#x003bc;g/mL), spectinomycin hydrochloride (50 &#x003bc;g/mL), and nalidixic acid (30 &#x003bc;g/mL) were used for the selection and maintenance of <italic toggle="yes">S. coelicolor</italic> recombinant strains. Vancomycin, teicoplanin, and A40926 were added to solid or liquid cultures at the desired concentrations reported in <xref rid="sec2-ijms-23-15713" ref-type="sec">Section 2</xref>. <italic toggle="yes">E. coli</italic> DH5&#x003b1; was used as a general cloning host, while <italic toggle="yes">E. coli</italic> ET12567 pUZ8002<sup>+</sup> was used as a donor for intergeneric matings. <italic toggle="yes">E. coli</italic> strains were cultivated at 37 &#x000b0;C in lysogeny broth or agar media supplemented with 100 &#x003bc;g/mL of apramycin sulfate, 50 &#x003bc;g/mL of kanamycin sulfate, and 25 &#x003bc;g/mL of chloramphenicol when appropriate. All antibiotics were purchased from Sigma-Aldrich (Merck Group, Darmstadt, Germany).</p></sec><sec id="sec4dot2-ijms-23-15713"><title>4.2. Generation of Recombinant Plasmids for Gene Expression and Promoter-Probe Vectors</title><p>In all cases described below, Q5 High-Fidelity DNA Polymerase (NEB, Ipswich, MA, USA) was used as a DNA polymerase of choice in PCRs according to the recommendations of the supplier. Restriction endonucleases and T4 DNA ligase from Thermo Fisher Scientific (Waltham, MA, USA) were always used for DNA digestion and ligation according to the supplier&#x02019;s recommendations. Chromosome DNA, utilized as a PCR template, was isolated according to the Kirby procedure [<xref rid="B45-ijms-23-15713" ref-type="bibr">45</xref>].</p><p><bold>pGP101, pGP111.</bold> The coding sequence of the <italic toggle="yes">tei3</italic> gene was amplified from the chromosome DNA of <italic toggle="yes">A. teichomyceticus</italic> using the tei3_F/R primer pair (<xref rid="ijms-23-15713-t002" ref-type="table">Table 2</xref>); the obtained 1133 bp amplicon was digested with <italic toggle="yes">Eco</italic>RI/<italic toggle="yes">Eco</italic>RV restriction endonucleases and cloned into the pSET152A vector digested with the same restriction endonucleases yielding pGP101. Further, pGP101 was digested with <italic toggle="yes">Bam</italic>HI/<italic toggle="yes">Xho</italic>I restriction endonuclease, and a 3247 bp DNA fragment carrying <italic toggle="yes">aac(3)IVp-tei3</italic> was purified; in parallel, the pRT801 plasmid was also digested with <italic toggle="yes">Bam</italic>HI/<italic toggle="yes">Xho</italic>I and the 3362 bp DNA fragment was purified. Both obtained fragments were then ligated, generating pGP111.</p><p><bold>pGP102, pKC1132-102, pKC1132-103, and pGP103.</bold> The coding sequence of <italic toggle="yes">vanSsc</italic> (<italic toggle="yes">SCO3589</italic>) was amplified using the chromosome DNA of <italic toggle="yes">S. coelicolor</italic> M512 as a template with the SCO3859_F/R primer pair; the obtained 1130 bp amplicon was digested with <italic toggle="yes">Eco</italic>RI/<italic toggle="yes">Eco</italic>RV restriction endonucleases and cloned into pSET152A via the same sites, giving pGP102. pGP102 was digested with <italic toggle="yes">Pvu</italic>II and the 1753 bp fragment (carrying <italic toggle="yes">aac(3)IVp-SCO3589</italic>) was cloned into pKC1132 digested with the same restriction endonuclease, generating pKC1132-102. Then, a fragment of <italic toggle="yes">SCO3589</italic> coding for the SD was exchanged for the corresponding fragment of <italic toggle="yes">tei3</italic>. The fragment of the <italic toggle="yes">tei3</italic> sequence coding for the SD was amplified from pGP101 using the tei3_F and tei3_sdomain_PaeI primers pair; the obtained 285 bp amplicon was digested with <italic toggle="yes">EcoR</italic>V and <italic toggle="yes">Pae</italic>I restriction endonucleases. In parallel, pKC1132-102 was also digested with <italic toggle="yes">EcoR</italic>V and <italic toggle="yes">Pae</italic>I and a 4289 bp fragment was selected; this latter fragment was ligated with the <italic toggle="yes">Pae</italic>I-digested <italic toggle="yes">tei3-SD</italic> amplicon, yielding pKC1132-103. Finally, the hybrid ORF of <italic toggle="yes">SCO3589</italic> with the SD-coding fragment exchanged with <italic toggle="yes">tei3-SD</italic> was excised from pKC1132-103 using <italic toggle="yes">Eco</italic>RV and <italic toggle="yes">Eco</italic>RI restriction endonucleases, and cloned into pSET152A via the same recognition sites generating pGP103.</p><p><bold>pGP104, pGP105, pGP106, and pGP107.</bold> These vectors carried truncated versions of <italic toggle="yes">tei3</italic> and <italic toggle="yes">SCO3589</italic> lacking parts of the sequence coding for (i) TMh1 (<italic toggle="yes">tei3&#x02032;</italic>&#x02014;pGP104; <italic toggle="yes">SCO3589&#x02032;</italic>&#x02014;pGP105) and (ii) whole SD (<italic toggle="yes">tei3&#x02033;</italic>&#x02014;pGP106; <italic toggle="yes">SCO3589&#x02033;</italic>&#x02014;pGP107). All these coding sequences were amplified using primers listed in <xref rid="ijms-23-15713-t002" ref-type="table">Table 2</xref>, generating: <italic toggle="yes">tei3&#x02032;</italic>&#x02014;956 bp; <italic toggle="yes">tei3&#x02033;</italic>&#x02014;879 bp; <italic toggle="yes">SCO3589&#x02032;</italic>&#x02014;959 bp; <italic toggle="yes">SCO3589&#x02033;</italic>&#x02014;878 bp. Amplicons were digested with <italic toggle="yes">Eco</italic>RV/<italic toggle="yes">Eco</italic>RI and cloned into pSET152A via the same recognition sites.</p><p><bold>pGJp and pGHp.</bold> DNA fragments including promoter regions of <italic toggle="yes">S. coelicolor vanJ (SCO3592)</italic> and <italic toggle="yes">vanH (SCO3594)</italic> genes were amplified from the chromosome DNA of <italic toggle="yes">S. coelicolor</italic> M512 using vanJp_KpnI_F/vanJp_SpeI_R and vanHp_KpnI_F/vanHp_SpeI_R primers pairs (<xref rid="ijms-23-15713-t002" ref-type="table">Table 2</xref>). The obtained amplicons for <italic toggle="yes">vanJp</italic> (321 bp) and <italic toggle="yes">vanHp</italic> (539 bp) were digested with <italic toggle="yes">Kpn</italic>I/<italic toggle="yes">Spe</italic>I restriction endonucleases and ligated with pGUS digested by the same enzymes, yielding pGJp and pGHp promoter-probe vectors.</p><p>All generated plasmids were verified by restriction mapping and sequencing.</p></sec><sec id="sec4dot3-ijms-23-15713"><title>4.3. Conjugal Transfer of Recombinant Plasmids to S. coelicolor Strains</title><p>A standard protocol for the conjugal transfer of plasmids to <italic toggle="yes">S. coelicolor</italic> strains was utilized [<xref rid="B45-ijms-23-15713" ref-type="bibr">45</xref>]. All necessary plasmids were individually transferred into the non-methylating <italic toggle="yes">E. coli</italic> ET12567 pUZ8002<sup>+</sup> and the resulting derivatives were used as donor strains for intergeneric conjugation, while spores of <italic toggle="yes">S. coelicolor</italic> were used as acceptors. Circa 10<sup>6</sup> spores were mixed with, ca., 10<sup>9</sup> donor cells and plated on ISP3 agar supplemented with MgCl<sub>2</sub> (10 mM); after 12 h of incubation at 30 &#x000b0;C, each plate was overlaid with 1 mL of sterile water with 1.25 mg of apramycin-sulfate and 750 &#x003bc;g of nalidixic acid. Transconjugants were selected as resistant to 50 &#x003bc;g/mL of apramycin sulfate or 50 &#x003bc;g/mL of spectinomycin hydrochloride. All recombinant strains were tested with PCR using chromosome DNA isolated according to the Kirby procedure [<xref rid="B45-ijms-23-15713" ref-type="bibr">45</xref>]. <italic toggle="yes">aac(3)IV</italic> was amplified from chromosome DNA of transconjugants carrying pSET152A and pRT801 derivatives with the aac(3)IV_F/R primer pair. Transconjugants carrying promoter-probe vectors were tested by amplifying the 1000 bp internal region of <italic toggle="yes">gusA</italic> with the gusA_ver_F/R primer pair (<xref rid="ijms-23-15713-t002" ref-type="table">Table 2</xref>).</p></sec><sec id="sec4dot4-ijms-23-15713"><title>4.4. Qualitative and Quantitative Glucuronidase Assays</title><p>Qualitatively, the &#x003b2;-glucuronidase (GusA) activity in <italic toggle="yes">S. coelicolor</italic> was assessed by adding 25 mg/mL of 5-bromo-4-chloro-3-indolyl-&#x003b2;-<sc>d</sc>-glucuronide (X-Gluc, Thermo Fisher Scientific, Waltham, MA, USA) to SMMS agar. The chromogenic conversion of X-Gluc into the green-colored 5,5&#x02032;-dibromo-4,4&#x02032;-dichloro-indigo was then monitored. Quantitative measurement was performed as follows. A number of 10<sup>7</sup> spores of <italic toggle="yes">S. coelicolor</italic> pGJp<sup>+</sup> and pGHp<sup>+</sup> were inoculated into a baffled 300 mL Erlenmeyer flask containing 50 mL of TSB and incubated without and with vancomycin as an inducer. Mycelium obtained in this way was used to prepare cell-free lysates as reported previously [<xref rid="B63-ijms-23-15713" ref-type="bibr">63</xref>]. Glucuronidase activity was measured in cell-free lysates as described previously [<xref rid="B44-ijms-23-15713" ref-type="bibr">44</xref>,<xref rid="B63-ijms-23-15713" ref-type="bibr">63</xref>] utilizing a spectrophotometric assay to detect the conversion of the colorless <italic toggle="yes">p</italic>-nitrophenyl-&#x003b2;-<sc>d</sc>-glucuronide (Thermo Fisher Scientific, Waltham, MA, USA) into the colored <italic toggle="yes">p</italic>-nitrophenol at 415 nm using a Unicam UV 500 UV-Visible Spectrometer (Thermo, Waltham, MA, USA). Glucuronidase activity was normalized to the weight of dry biomass, and one unit of activity was considered as the amount of enzyme able to convert 1 &#x003bc;M of the substrate in 1 min.</p></sec><sec id="sec4dot5-ijms-23-15713"><title>4.5. Tools for In Silico Analysis</title><p>Clustal Omega (EMBL-EBI) [<xref rid="B41-ijms-23-15713" ref-type="bibr">41</xref>] was used for pairwise alignment of aa and nucleic acid sequences. CD-Search was used to identify conserved domain regions [<xref rid="B42-ijms-23-15713" ref-type="bibr">42</xref>]. G<sc>eneious</sc> 4.8.5 was utilized for routine analysis of aa and nucleic acid sequences [<xref rid="B64-ijms-23-15713" ref-type="bibr">64</xref>]. MEGA11 (v.11.0.13) was used to perform phylogenetic reconstruction [<xref rid="B58-ijms-23-15713" ref-type="bibr">58</xref>].</p></sec></sec></body><back><ack><title>Acknowledgments</title><p>We thank Mark Buttner (John Innes Centre) for kindly providing us with <italic toggle="yes">S. coelicolor</italic> M512 and J3200 strains and Margaret Smith (University of York) for kindly providing us with the pRT801 vector.</p></ack><fn-group><fn><p><bold>Publisher&#x02019;s Note:</bold> MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group><app-group><app id="app1-ijms-23-15713"><title>Supplementary Materials</title><p>The following supporting information can be downloaded at: <uri xlink:href="https://www.mdpi.com/article/10.3390/ijms232415713/s1">https://www.mdpi.com/article/10.3390/ijms232415713/s1</uri>.</p><supplementary-material id="ijms-23-15713-s001" position="float" content-type="local-data"><media xlink:href="ijms-23-15713-s001.zip"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material></app></app-group><notes><title>Author Contributions</title><p>Conceptualization, O.Y., B.O., V.F. and F.M.; formal analysis, O.Y.; investigation, O.Y. and K.Z.; writing&#x02014;original draft, O.Y. and F.M. All authors have read and agreed to the published version of the manuscript.</p></notes><notes><title>Institutional Review Board Statement</title><p>Not applicable.</p></notes><notes><title>Informed Consent Statement</title><p>Not applicable.</p></notes><notes notes-type="data-availability"><title>Data Availability Statement</title><p>All the data are available from the corresponding author upon reasonable request.</p></notes><notes notes-type="COI-statement"><title>Conflicts of Interest</title><p>The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.</p></notes><ref-list><title>References</title><ref id="B1-ijms-23-15713"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Nicolaou</surname><given-names>K.C.</given-names></name>
<name><surname>Boddy</surname><given-names>C.N.C.</given-names></name>
<name><surname>Br&#x000e4;se</surname><given-names>S.</given-names></name>
<name><surname>Winssinger</surname><given-names>N.</given-names></name>
</person-group><article-title>Chemistry, biology, and medicine of the glycopeptide antibiotics</article-title><source>Angew. Chem. Int. Ed.</source><year>1999</year><volume>38</volume><fpage>2096</fpage><lpage>2152</lpage><pub-id pub-id-type="doi">10.1002/(SICI)1521-3773(19990802)38:15&#x0003c;2096::AID-ANIE2096&#x0003e;3.0.CO;2-F</pub-id></element-citation></ref><ref id="B2-ijms-23-15713"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Parenti</surname><given-names>F.</given-names></name>
<name><surname>Cavalleri</surname><given-names>B.</given-names></name>
</person-group><article-title>Proposal to name the vancomycin-ristocetin like glycopeptides as dalbaheptides</article-title><source>J. Antibiot.</source><year>1989</year><volume>42</volume><fpage>1882</fpage><lpage>1883</lpage><pub-id pub-id-type="doi">10.7164/antibiotics.42.1882</pub-id><?supplied-pmid 2621171?><pub-id pub-id-type="pmid">2621171</pub-id></element-citation></ref><ref id="B3-ijms-23-15713"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Marcone</surname><given-names>G.L.</given-names></name>
<name><surname>Binda</surname><given-names>E.</given-names></name>
<name><surname>Berini</surname><given-names>F.</given-names></name>
<name><surname>Marinelli</surname><given-names>F.</given-names></name>
</person-group><article-title>Old and new glycopeptide antibiotics: From product to gene and back in the post-genomic era</article-title><source>Biotechnol. Adv.</source><year>2018</year><volume>36</volume><fpage>534</fpage><lpage>554</lpage><pub-id pub-id-type="doi">10.1016/j.biotechadv.2018.02.009</pub-id><?supplied-pmid 29454983?><pub-id pub-id-type="pmid">29454983</pub-id></element-citation></ref><ref id="B4-ijms-23-15713"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Binda</surname><given-names>E.</given-names></name>
<name><surname>Marinelli</surname><given-names>F.</given-names></name>
<name><surname>Marcone</surname><given-names>G.L.</given-names></name>
</person-group><article-title>Old and new glycopeptide antibiotics: Action and resistance</article-title><source>Antibiotics</source><year>2014</year><volume>3</volume><fpage>572</fpage><lpage>594</lpage><pub-id pub-id-type="doi">10.3390/antibiotics3040572</pub-id><?supplied-pmid 27025757?><pub-id pub-id-type="pmid">27025757</pub-id></element-citation></ref><ref id="B5-ijms-23-15713"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Thaker</surname><given-names>M.N.</given-names></name>
<name><surname>Wright</surname><given-names>G.D.</given-names></name>
</person-group><article-title>Opportunities for synthetic biology in antibiotics: Expanding glycopeptide chemical diversity</article-title><source>ACS Synth. Biol.</source><year>2015</year><volume>4</volume><fpage>195</fpage><lpage>206</lpage><pub-id pub-id-type="doi">10.1021/sb300092n</pub-id><?supplied-pmid 23654249?><pub-id pub-id-type="pmid">23654249</pub-id></element-citation></ref><ref id="B6-ijms-23-15713"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Butler</surname><given-names>M.S.</given-names></name>
<name><surname>Hansford</surname><given-names>K.A.</given-names></name>
<name><surname>Blaskovich</surname><given-names>M.A.T.</given-names></name>
<name><surname>Halai</surname><given-names>R.</given-names></name>
<name><surname>Cooper</surname><given-names>M.A.</given-names></name>
</person-group><article-title>Glycopeptide antibiotics: Back to the future</article-title><source>J. Antibiot.</source><year>2014</year><volume>67</volume><fpage>631</fpage><lpage>644</lpage><pub-id pub-id-type="doi">10.1038/ja.2014.111</pub-id></element-citation></ref><ref id="B7-ijms-23-15713"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Van Bambeke</surname><given-names>F.</given-names></name>
</person-group><article-title>Lipoglycopeptide antibacterial agents in gram-positive infections: A comparative review</article-title><source>Drugs</source><year>2015</year><volume>75</volume><fpage>2073</fpage><lpage>2095</lpage><pub-id pub-id-type="doi">10.1007/s40265-015-0505-8</pub-id><pub-id pub-id-type="pmid">26603874</pub-id></element-citation></ref><ref id="B8-ijms-23-15713"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>McCormick</surname><given-names>M.H.</given-names></name>
<name><surname>McGuire</surname><given-names>J.M.</given-names></name>
<name><surname>Pittenger</surname><given-names>G.E.</given-names></name>
<name><surname>Pittenger</surname><given-names>R.C.</given-names></name>
<name><surname>Stark</surname><given-names>W.M.</given-names></name>
</person-group><article-title>Vancomycin, a new antibiotic. I. Chemical and biologic properties</article-title><source>Antibiot. Annu.</source><year>1955</year><volume>3</volume><fpage>606</fpage><lpage>611</lpage><pub-id pub-id-type="pmid">13355336</pub-id></element-citation></ref><ref id="B9-ijms-23-15713"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Malabarba</surname><given-names>A.</given-names></name>
<name><surname>Strazzolini</surname><given-names>P.</given-names></name>
<name><surname>Depaoli</surname><given-names>A.</given-names></name>
<name><surname>Landi</surname><given-names>M.</given-names></name>
<name><surname>Berti</surname><given-names>M.</given-names></name>
<name><surname>Cavalleri</surname><given-names>B.</given-names></name>
</person-group><article-title>Teicoplanin, antibiotics from <italic toggle="yes">Actinoplanes teichomyceticus</italic> nov. sp. VI. Chemical degradation: Physico-chemical and biological properties of acid hydrolysis products</article-title><source>J. Antibiot.</source><year>1984</year><volume>37</volume><fpage>988</fpage><lpage>999</lpage><pub-id pub-id-type="doi">10.7164/antibiotics.37.988</pub-id></element-citation></ref><ref id="B10-ijms-23-15713"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Leadbetter</surname><given-names>M.R.</given-names></name>
<name><surname>Adams</surname><given-names>S.M.</given-names></name>
<name><surname>Bazzini</surname><given-names>B.</given-names></name>
<name><surname>Fatheree</surname><given-names>P.R.</given-names></name>
<name><surname>Karr</surname><given-names>D.E.</given-names></name>
<name><surname>Krause</surname><given-names>K.M.</given-names></name>
<name><surname>Lam</surname><given-names>B.M.T.</given-names></name>
<name><surname>Linsell</surname><given-names>M.S.</given-names></name>
<name><surname>Nodwell</surname><given-names>M.B.</given-names></name>
<name><surname>Pace</surname><given-names>J.L.</given-names></name>
<etal/>
</person-group><article-title>Hydrophobic vancomycin derivatives with improved ADME properties: Discovery of telavancin (TD-6424)</article-title><source>J. Antibiot.</source><year>2004</year><volume>57</volume><fpage>326</fpage><lpage>336</lpage><pub-id pub-id-type="doi">10.7164/antibiotics.57.326</pub-id></element-citation></ref><ref id="B11-ijms-23-15713"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Cooper</surname><given-names>R.D.</given-names></name>
<name><surname>Snyder</surname><given-names>N.J.</given-names></name>
<name><surname>Zweifel</surname><given-names>M.J.</given-names></name>
<name><surname>Staszak</surname><given-names>M.A.</given-names></name>
<name><surname>Wilkie</surname><given-names>S.C.</given-names></name>
<name><surname>Nicas</surname><given-names>T.I.</given-names></name>
<name><surname>Mullen</surname><given-names>D.L.</given-names></name>
<name><surname>Butler</surname><given-names>T.F.</given-names></name>
<name><surname>Rodriguez</surname><given-names>M.J.</given-names></name>
<name><surname>Huff</surname><given-names>B.E.</given-names></name>
<etal/>
</person-group><article-title>Reductive alkylation of glycopeptide antibiotics: Synthesis and antibacterial activity</article-title><source>J. Antibiot.</source><year>1996</year><volume>49</volume><fpage>575</fpage><lpage>581</lpage><pub-id pub-id-type="doi">10.7164/antibiotics.49.575</pub-id><?supplied-pmid 8698642?><pub-id pub-id-type="pmid">8698642</pub-id></element-citation></ref><ref id="B12-ijms-23-15713"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Steiert</surname><given-names>M.</given-names></name>
<name><surname>Schmitz</surname><given-names>F.-J.</given-names></name>
</person-group><article-title>Dalbavancin (Biosearch Italia/Versicor)</article-title><source>Curr. Opin. Investig. Drugs</source><year>2002</year><volume>3</volume><fpage>229</fpage><lpage>233</lpage><?supplied-pmid 12020051?><pub-id pub-id-type="pmid">12020051</pub-id></element-citation></ref><ref id="B13-ijms-23-15713"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Melegh</surname><given-names>S.</given-names></name>
<name><surname>Nyul</surname><given-names>A.</given-names></name>
<name><surname>Kov&#x000e1;cs</surname><given-names>K.</given-names></name>
<name><surname>Kov&#x000e1;cs</surname><given-names>T.</given-names></name>
<name><surname>Ghid&#x000e1;n</surname><given-names>&#x000c1;.</given-names></name>
<name><surname>Dombr&#x000e1;di</surname><given-names>Z.</given-names></name>
<name><surname>Szab&#x000f3;</surname><given-names>J.</given-names></name>
<name><surname>Berta</surname><given-names>B.</given-names></name>
<name><surname>Lesinszki</surname><given-names>V.</given-names></name>
<name><surname>P&#x000e1;szti</surname><given-names>J.</given-names></name>
<etal/>
</person-group><article-title>Dissemination of VanA-type <italic toggle="yes">Enterococcus faecium</italic> isolates in Hungary</article-title><source>Microb. Drug Resist.</source><year>2018</year><volume>24</volume><fpage>1376</fpage><lpage>1390</lpage><pub-id pub-id-type="doi">10.1089/mdr.2017.0296</pub-id><?supplied-pmid 29750597?><pub-id pub-id-type="pmid">29750597</pub-id></element-citation></ref><ref id="B14-ijms-23-15713"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Gold</surname><given-names>H.S.</given-names></name>
</person-group><article-title>Vancomycin-resistant enterococci: Mechanisms and clinical observations</article-title><source>Clin. Infect. Dis.</source><year>2001</year><volume>33</volume><fpage>210</fpage><lpage>219</lpage><pub-id pub-id-type="doi">10.1086/321815</pub-id><pub-id pub-id-type="pmid">11418881</pub-id></element-citation></ref><ref id="B15-ijms-23-15713"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Boneca</surname><given-names>I.G.</given-names></name>
<name><surname>Chiosis</surname><given-names>G.</given-names></name>
</person-group><article-title>Vancomycin resistance: Occurrence, mechanisms and strategies to combat it</article-title><source>Expert Opin. Ther. Targets</source><year>2003</year><volume>7</volume><fpage>311</fpage><lpage>328</lpage><pub-id pub-id-type="doi">10.1517/14728222.7.3.311</pub-id><pub-id pub-id-type="pmid">12783569</pub-id></element-citation></ref><ref id="B16-ijms-23-15713"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Pootoolal</surname><given-names>J.</given-names></name>
<name><surname>Neu</surname><given-names>J.</given-names></name>
<name><surname>Wright</surname><given-names>G.D.</given-names></name>
</person-group><article-title>Glycopeptide antibiotic resistance</article-title><source>Annu. Rev. Pharmacol. Toxicol.</source><year>2002</year><volume>42</volume><fpage>381</fpage><lpage>408</lpage><pub-id pub-id-type="doi">10.1146/annurev.pharmtox.42.091601.142813</pub-id><pub-id pub-id-type="pmid">11807177</pub-id></element-citation></ref><ref id="B17-ijms-23-15713"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Marshall</surname><given-names>C.G.</given-names></name>
<name><surname>Broadhead</surname><given-names>G.</given-names></name>
<name><surname>Leskiw</surname><given-names>B.K.</given-names></name>
<name><surname>Wright</surname><given-names>G.D.</given-names></name>
</person-group><article-title><sc>d</sc>-Ala-<sc>d</sc>-Ala ligases from glycopeptide antibiotic-producing organisms are highly homologous to the enterococcal vancomycin-resistance ligases VanA and VanB</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>1997</year><volume>94</volume><fpage>6480</fpage><lpage>6483</lpage><pub-id pub-id-type="doi">10.1073/pnas.94.12.6480</pub-id><pub-id pub-id-type="pmid">9177243</pub-id></element-citation></ref><ref id="B18-ijms-23-15713"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Andreo-Vidal</surname><given-names>A.</given-names></name>
<name><surname>Binda</surname><given-names>E.</given-names></name>
<name><surname>Fedorenko</surname><given-names>V.</given-names></name>
<name><surname>Marinelli</surname><given-names>F.</given-names></name>
<name><surname>Yushchuk</surname><given-names>O.</given-names></name>
</person-group><article-title>Genomic insights into the distribution and phylogeny of glycopeptide resistance determinants within the <italic toggle="yes">Actinobacteria</italic> phylum</article-title><source>Antibiotics</source><year>2021</year><volume>10</volume><elocation-id>1533</elocation-id><pub-id pub-id-type="doi">10.3390/antibiotics10121533</pub-id><pub-id pub-id-type="pmid">34943745</pub-id></element-citation></ref><ref id="B19-ijms-23-15713"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Yushchuk</surname><given-names>O.</given-names></name>
<name><surname>Binda</surname><given-names>E.</given-names></name>
<name><surname>Fedorenko</surname><given-names>V.</given-names></name>
<name><surname>Marinelli</surname><given-names>F.</given-names></name>
</person-group><article-title>Occurrence of <italic toggle="yes">vanHAX</italic> and related genes beyond the <italic toggle="yes">Actinobacteria</italic> phylum</article-title><source>Genes</source><year>2022</year><volume>13</volume><elocation-id>1960</elocation-id><pub-id pub-id-type="doi">10.3390/genes13111960</pub-id><pub-id pub-id-type="pmid">36360197</pub-id></element-citation></ref><ref id="B20-ijms-23-15713"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Williams</surname><given-names>D.H.</given-names></name>
</person-group><article-title>The glycopeptide story&#x02014;How to kill the deadly &#x0201c;superbugs&#x0201d;</article-title><source>Nat. Prod. Rep.</source><year>1996</year><volume>13</volume><fpage>469</fpage><lpage>477</lpage><pub-id pub-id-type="doi">10.1039/NP9961300469</pub-id><pub-id pub-id-type="pmid">8972102</pub-id></element-citation></ref><ref id="B21-ijms-23-15713"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Arthur</surname><given-names>M.</given-names></name>
<name><surname>Molinas</surname><given-names>C.</given-names></name>
<name><surname>Bugg</surname><given-names>T.D.H.</given-names></name>
<name><surname>Wright</surname><given-names>G.D.</given-names></name>
<name><surname>Walsh</surname><given-names>C.T.</given-names></name>
<name><surname>Courvalin</surname><given-names>P.</given-names></name>
</person-group><article-title>Evidence for in vivo incorporation of <sc>d</sc>-lactate into peptidoglycan precursors of vancomycin-resistant enterococci</article-title><source>Antimicrob. Agents Chemother.</source><year>1992</year><volume>36</volume><fpage>867</fpage><lpage>869</lpage><pub-id pub-id-type="doi">10.1128/AAC.36.4.867</pub-id><?supplied-pmid 1503450?><pub-id pub-id-type="pmid">1503450</pub-id></element-citation></ref><ref id="B22-ijms-23-15713"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Marcone</surname><given-names>G.L.</given-names></name>
<name><surname>Beltrametti</surname><given-names>F.</given-names></name>
<name><surname>Binda</surname><given-names>E.</given-names></name>
<name><surname>Carrano</surname><given-names>L.</given-names></name>
<name><surname>Foulston</surname><given-names>L.</given-names></name>
<name><surname>Hesketh</surname><given-names>A.</given-names></name>
<name><surname>Bibb</surname><given-names>M.</given-names></name>
<name><surname>Marinelli</surname><given-names>F.</given-names></name>
</person-group><article-title>Novel mechanism of glycopeptide resistance in the A40926 producer <italic toggle="yes">Nonomuraea</italic> sp. ATCC 39727</article-title><source>Antimicrob. Agents Chemother.</source><year>2010</year><volume>54</volume><fpage>2465</fpage><lpage>2472</lpage><pub-id pub-id-type="doi">10.1128/AAC.00106-10</pub-id><pub-id pub-id-type="pmid">20308385</pub-id></element-citation></ref><ref id="B23-ijms-23-15713"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Marcone</surname><given-names>G.L.</given-names></name>
<name><surname>Binda</surname><given-names>E.</given-names></name>
<name><surname>Carrano</surname><given-names>L.</given-names></name>
<name><surname>Bibb</surname><given-names>M.</given-names></name>
<name><surname>Marinelli</surname><given-names>F.</given-names></name>
</person-group><article-title>Relationship between glycopeptide production and resistance in the actinomycete <italic toggle="yes">Nonomuraea</italic> sp. ATCC 39727</article-title><source>Antimicrob. Agents Chemother.</source><year>2014</year><volume>58</volume><fpage>5191</fpage><lpage>5201</lpage><pub-id pub-id-type="doi">10.1128/AAC.02626-14</pub-id><pub-id pub-id-type="pmid">24957828</pub-id></element-citation></ref><ref id="B24-ijms-23-15713"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Binda</surname><given-names>E.</given-names></name>
<name><surname>Marcone</surname><given-names>G.L.</given-names></name>
<name><surname>Pollegioni</surname><given-names>L.</given-names></name>
<name><surname>Marinelli</surname><given-names>F.</given-names></name>
</person-group><article-title>Characterization of VanY<sub>n</sub>, a novel <sc>d</sc>,<sc>d</sc>-peptidase/<sc>d</sc>,<sc>d- </sc>carboxypeptidase involved in glycopeptide antibiotic resistance in <italic toggle="yes">Nonomuraea</italic> sp. ATCC 39727</article-title><source>FEBS J.</source><year>2012</year><volume>279</volume><fpage>3203</fpage><lpage>3213</lpage><pub-id pub-id-type="doi">10.1111/j.1742-4658.2012.08706.x</pub-id><?supplied-pmid 22788848?><pub-id pub-id-type="pmid">22788848</pub-id></element-citation></ref><ref id="B25-ijms-23-15713"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Reynolds</surname><given-names>P.E.</given-names></name>
<name><surname>Depardieu</surname><given-names>F.</given-names></name>
<name><surname>Dutka-Malen</surname><given-names>S.</given-names></name>
<name><surname>Arthur</surname><given-names>M.</given-names></name>
<name><surname>Courvalin</surname><given-names>P.</given-names></name>
</person-group><article-title>Glycopeptide resistance mediated by enterococcal transposon Tn1546 requires production of VanX for hydrolysis of <sc>d</sc>-alanyl-<sc>d</sc>-alanine</article-title><source>Mol. Microbiol.</source><year>1994</year><volume>13</volume><fpage>1065</fpage><lpage>1070</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2958.1994.tb00497.x</pub-id><?supplied-pmid 7854121?><pub-id pub-id-type="pmid">7854121</pub-id></element-citation></ref><ref id="B26-ijms-23-15713"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Wu</surname><given-names>Z.</given-names></name>
<name><surname>Wright</surname><given-names>G.D.</given-names></name>
<name><surname>Walsh</surname><given-names>C.T.</given-names></name>
</person-group><article-title>Overexpression, purification, and characterization of VanX, a <sc>d</sc>-,<sc>d</sc>-dipeptidase which is essential for vancomycin resistance in <italic toggle="yes">Enterococcus faecium</italic> BM4147</article-title><source>Biochemistry</source><year>1995</year><volume>34</volume><fpage>2455</fpage><lpage>2463</lpage><pub-id pub-id-type="doi">10.1021/bi00008a008</pub-id><?supplied-pmid 7873524?><pub-id pub-id-type="pmid">7873524</pub-id></element-citation></ref><ref id="B27-ijms-23-15713"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Bugg</surname><given-names>T.D.</given-names></name>
<name><surname>Wright</surname><given-names>G.D.</given-names></name>
<name><surname>Dutka-Malen</surname><given-names>S.</given-names></name>
<name><surname>Arthur</surname><given-names>M.</given-names></name>
<name><surname>Courvalin</surname><given-names>P.</given-names></name>
<name><surname>Walsh</surname><given-names>C.T.</given-names></name>
</person-group><article-title>Molecular basis for vancomycin resistance in <italic toggle="yes">Enterococcus faecium</italic> BM4147: Biosynthesis of a depsipeptide peptidoglycan precursor by vancomycin resistance proteins VanH and VanA</article-title><source>Biochemistry</source><year>1991</year><volume>30</volume><fpage>10408</fpage><lpage>10415</lpage><pub-id pub-id-type="doi">10.1021/bi00107a007</pub-id><pub-id pub-id-type="pmid">1931965</pub-id></element-citation></ref><ref id="B28-ijms-23-15713"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Arthur</surname><given-names>M.</given-names></name>
<name><surname>Quintiliani</surname><given-names>R.</given-names><suffix>Jr.</suffix></name>
</person-group><article-title>Regulation of VanA- and VanB-type glycopeptide resistance in enterococci</article-title><source>Antimicrob. Agents Chemother.</source><year>2001</year><volume>45</volume><fpage>375</fpage><lpage>381</lpage><pub-id pub-id-type="doi">10.1128/AAC.45.2.375-381.2001</pub-id><pub-id pub-id-type="pmid">11158729</pub-id></element-citation></ref><ref id="B29-ijms-23-15713"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Koteva</surname><given-names>K.</given-names></name>
<name><surname>Hong</surname><given-names>H.J.</given-names></name>
<name><surname>Wang</surname><given-names>X.D.</given-names></name>
<name><surname>Nazi</surname><given-names>I.</given-names></name>
<name><surname>Hughes</surname><given-names>D.</given-names></name>
<name><surname>Naldrett</surname><given-names>M.J.</given-names></name>
<name><surname>Buttner</surname><given-names>M.J.</given-names></name>
<name><surname>Wright</surname><given-names>G.D.</given-names></name>
</person-group><article-title>A vancomycin photoprobe identifies the histidine kinase VanS<sub>sc</sub> as a vancomycin receptor</article-title><source>Nat. Chem. Biol.</source><year>2010</year><volume>6</volume><fpage>327</fpage><lpage>329</lpage><pub-id pub-id-type="doi">10.1038/nchembio.350</pub-id><pub-id pub-id-type="pmid">20383152</pub-id></element-citation></ref><ref id="B30-ijms-23-15713"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kwun</surname><given-names>M.J.</given-names></name>
<name><surname>Novotna</surname><given-names>G.</given-names></name>
<name><surname>Hesketh</surname><given-names>A.R.</given-names></name>
<name><surname>Hill</surname><given-names>L.</given-names></name>
<name><surname>Hong</surname><given-names>H.J.</given-names></name>
</person-group><article-title>In vivo studies suggest that induction of VanS-dependent vancomycin resistance requires binding of the drug to <sc>d</sc>-Ala-<sc>d</sc>-Ala termini in the peptidoglycan cell wall</article-title><source>Antimicrob. Agents Chemother.</source><year>2013</year><volume>57</volume><fpage>4470</fpage><lpage>4480</lpage><pub-id pub-id-type="doi">10.1128/AAC.00523-13</pub-id><pub-id pub-id-type="pmid">23836175</pub-id></element-citation></ref><ref id="B31-ijms-23-15713"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Hutchings</surname><given-names>M.I.</given-names></name>
<name><surname>Hong</surname><given-names>H.J.</given-names></name>
<name><surname>Buttner</surname><given-names>M.J.</given-names></name>
</person-group><article-title>The vancomycin resistance VanRS two-component signal transduction system of <italic toggle="yes">Streptomyces coelicolor</italic></article-title><source>Mol. Microbiol.</source><year>2006</year><volume>59</volume><fpage>923</fpage><lpage>935</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2958.2005.04953.x</pub-id><?supplied-pmid 16420361?><pub-id pub-id-type="pmid">16420361</pub-id></element-citation></ref><ref id="B32-ijms-23-15713"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Hong</surname><given-names>H.J.</given-names></name>
<name><surname>Paget</surname><given-names>M.S.B.</given-names></name>
<name><surname>Buttner</surname><given-names>M.J.</given-names></name>
</person-group><article-title>A signal transduction system in <italic toggle="yes">Streptomyces coelicolor</italic> that activates expression of a putative cell wall glycan operon in response to vancomycin and other cell wall-specific antibiotics</article-title><source>Mol. Microbiol.</source><year>2002</year><volume>44</volume><fpage>1199</fpage><lpage>1211</lpage><pub-id pub-id-type="doi">10.1046/j.1365-2958.2002.02960.x</pub-id><?supplied-pmid 12068806?><pub-id pub-id-type="pmid">12068806</pub-id></element-citation></ref><ref id="B33-ijms-23-15713"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Novotna</surname><given-names>G.B.</given-names></name>
<name><surname>Kwun</surname><given-names>M.J.</given-names></name>
<name><surname>Hong</surname><given-names>H.J.</given-names></name>
</person-group><article-title>In vivo characterization of the activation and interaction of the VanR-VanS two-component regulatory system controlling glycopeptide antibiotic resistance in two related <italic toggle="yes">Streptomyces</italic> species</article-title><source>Antimicrob. Agents Chemother.</source><year>2016</year><volume>60</volume><fpage>1627</fpage><lpage>1637</lpage><pub-id pub-id-type="doi">10.1128/AAC.01367-15</pub-id><?supplied-pmid 26711760?><pub-id pub-id-type="pmid">26711760</pub-id></element-citation></ref><ref id="B34-ijms-23-15713"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Yushchuk</surname><given-names>O.</given-names></name>
<name><surname>Binda</surname><given-names>E.</given-names></name>
<name><surname>Marinelli</surname><given-names>F.</given-names></name>
</person-group><article-title>Glycopeptide antibiotic resistance genes: Distribution and function in the producer actinomycetes</article-title><source>Front. Microbiol.</source><year>2020</year><volume>11</volume><fpage>1173</fpage><pub-id pub-id-type="doi">10.3389/fmicb.2020.01173</pub-id><pub-id pub-id-type="pmid">32655512</pub-id></element-citation></ref><ref id="B35-ijms-23-15713"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Beltrametti</surname><given-names>F.</given-names></name>
<name><surname>Consolandi</surname><given-names>A.</given-names></name>
<name><surname>Carrano</surname><given-names>L.</given-names></name>
<name><surname>Bagatin</surname><given-names>F.</given-names></name>
<name><surname>Rossi</surname><given-names>R.</given-names></name>
<name><surname>Leoni</surname><given-names>L.</given-names></name>
<name><surname>Zennaro</surname><given-names>E.</given-names></name>
<name><surname>Selva</surname><given-names>E.</given-names></name>
<name><surname>Marinelli</surname><given-names>F.</given-names></name>
</person-group><article-title>Resistance to glycopeptide antibiotics in the teicoplanin producer is mediated by <italic toggle="yes">van</italic> gene homologue expression directing the synthesis of a modified cell wall peptidoglycan</article-title><source>Antimicrob. Agents Chemother.</source><year>2007</year><volume>51</volume><fpage>1135</fpage><lpage>1141</lpage><pub-id pub-id-type="doi">10.1128/AAC.01071-06</pub-id><pub-id pub-id-type="pmid">17220405</pub-id></element-citation></ref><ref id="B36-ijms-23-15713"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Yushchuk</surname><given-names>O.</given-names></name>
<name><surname>Horbal</surname><given-names>L.</given-names></name>
<name><surname>Ostash</surname><given-names>B.</given-names></name>
<name><surname>Marinelli</surname><given-names>F.</given-names></name>
<name><surname>Wohlleben</surname><given-names>W.</given-names></name>
<name><surname>Stegmann</surname><given-names>E.</given-names></name>
<name><surname>Fedorenko</surname><given-names>V.</given-names></name>
</person-group><article-title>Regulation of teicoplanin biosynthesis: Refining the roles of <italic toggle="yes">tei</italic> cluster-situated regulatory genes</article-title><source>Appl. Microbiol. Biotechnol.</source><year>2019</year><volume>103</volume><fpage>4089</fpage><lpage>4102</lpage><pub-id pub-id-type="doi">10.1007/s00253-019-09789-w</pub-id><pub-id pub-id-type="pmid">30937499</pub-id></element-citation></ref><ref id="B37-ijms-23-15713"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Yushchuk</surname><given-names>O.</given-names></name>
<name><surname>Homoniuk</surname><given-names>V.</given-names></name>
<name><surname>Ostash</surname><given-names>B.</given-names></name>
<name><surname>Marinelli</surname><given-names>F.</given-names></name>
<name><surname>Fedorenko</surname><given-names>V.</given-names></name>
</person-group><article-title>Genetic insights into the mechanism of teicoplanin self-resistance in <italic toggle="yes">Actinoplanes teichomyceticus</italic></article-title><source>J. Antibiot.</source><year>2020</year><volume>73</volume><fpage>255</fpage><lpage>259</lpage><pub-id pub-id-type="doi">10.1038/s41429-019-0274-9</pub-id></element-citation></ref><ref id="B38-ijms-23-15713"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Floriano</surname><given-names>B.</given-names></name>
<name><surname>Bibb</surname><given-names>M.</given-names></name>
</person-group><article-title><italic toggle="yes">afsR</italic> is a pleiotropic but conditionally required regulatory gene for antibiotic production in <italic toggle="yes">Streptomyces coelicolor</italic> A3(2)</article-title><source>Mol. Microbiol.</source><year>1996</year><volume>21</volume><fpage>385</fpage><lpage>396</lpage><pub-id pub-id-type="doi">10.1046/j.1365-2958.1996.6491364.x</pub-id><pub-id pub-id-type="pmid">8858592</pub-id></element-citation></ref><ref id="B39-ijms-23-15713"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Hong</surname><given-names>H.J.</given-names></name>
<name><surname>Hutchings</surname><given-names>M.I.</given-names></name>
<name><surname>Neu</surname><given-names>J.M.</given-names></name>
<name><surname>Wright</surname><given-names>G.D.</given-names></name>
<name><surname>Paget</surname><given-names>M.S.B.</given-names></name>
<name><surname>Buttner</surname><given-names>M.J.</given-names></name>
</person-group><article-title>Characterization of an inducible vancomycin resistance system in <italic toggle="yes">Streptomyces coelicolor</italic> reveals a novel gene (<italic toggle="yes">vanK</italic>) required for drug resistance</article-title><source>Mol. Microbiol.</source><year>2004</year><volume>52</volume><fpage>1107</fpage><lpage>1121</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2958.2004.04032.x</pub-id><pub-id pub-id-type="pmid">15130128</pub-id></element-citation></ref><ref id="B40-ijms-23-15713"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kilian</surname><given-names>R.</given-names></name>
<name><surname>Frasch</surname><given-names>H.J.</given-names></name>
<name><surname>Kulik</surname><given-names>A.</given-names></name>
<name><surname>Wohlleben</surname><given-names>W.</given-names></name>
<name><surname>Stegmann</surname><given-names>E.</given-names></name>
</person-group><article-title>The VanRS homologous two-component system VnlRS<sub>Ab</sub> of the glycopeptide producer <italic toggle="yes">Amycolatopsis balhimycina</italic> activates transcription of the <italic toggle="yes">vanHAX<sub>Sc</sub></italic> genes in <italic toggle="yes">Streptomyces coelicolor</italic>, but not in <italic toggle="yes">A. balhimycina</italic></article-title><source>Microb. Drug Resist.</source><year>2016</year><volume>22</volume><fpage>499</fpage><lpage>509</lpage><pub-id pub-id-type="doi">10.1089/mdr.2016.0128</pub-id><pub-id pub-id-type="pmid">27420548</pub-id></element-citation></ref><ref id="B41-ijms-23-15713"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Sievers</surname><given-names>F.</given-names></name>
<name><surname>Higgins</surname><given-names>D.G.</given-names></name>
</person-group><article-title>Clustal omega</article-title><source>Curr. Protoc. Bioinform.</source><year>2014</year><volume>48</volume><fpage>1</fpage><lpage>33</lpage><pub-id pub-id-type="doi">10.1002/0471250953.bi0313s48</pub-id><?supplied-pmid 25501942?><pub-id pub-id-type="pmid">25501942</pub-id></element-citation></ref><ref id="B42-ijms-23-15713"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Marchler-Bauer</surname><given-names>A.</given-names></name>
<name><surname>Bryant</surname><given-names>S.H.</given-names></name>
</person-group><article-title>CD-Search: Protein domain annotations on the fly</article-title><source>Nucleic Acids Res.</source><year>2004</year><volume>32</volume><fpage>327</fpage><lpage>331</lpage><pub-id pub-id-type="doi">10.1093/nar/gkh454</pub-id><?supplied-pmid 15215404?><pub-id pub-id-type="pmid">15215404</pub-id></element-citation></ref><ref id="B43-ijms-23-15713"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Binda</surname><given-names>E.</given-names></name>
<name><surname>Cappelletti</surname><given-names>P.</given-names></name>
<name><surname>Marinelli</surname><given-names>F.</given-names></name>
<name><surname>Marcone</surname><given-names>G.L.</given-names></name>
</person-group><article-title>Specificity of induction of glycopeptide antibiotic resistance in the producing actinomycetes</article-title><source>Antibiotics</source><year>2018</year><volume>7</volume><elocation-id>36</elocation-id><pub-id pub-id-type="doi">10.3390/antibiotics7020036</pub-id><pub-id pub-id-type="pmid">29693566</pub-id></element-citation></ref><ref id="B44-ijms-23-15713"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Myronovskyi</surname><given-names>M.</given-names></name>
<name><surname>Welle</surname><given-names>E.</given-names></name>
<name><surname>Fedorenko</surname><given-names>V.</given-names></name>
<name><surname>Luzhetskyy</surname><given-names>A.</given-names></name>
</person-group><article-title>&#x003b2;-Glucuronidase as a sensitive and versatile reporter in <italic toggle="yes">Actinomycetes</italic></article-title><source>Appl. Environ. Microbiol.</source><year>2011</year><volume>77</volume><fpage>5370</fpage><lpage>5383</lpage><pub-id pub-id-type="doi">10.1128/AEM.00434-11</pub-id><?supplied-pmid 21685164?><pub-id pub-id-type="pmid">21685164</pub-id></element-citation></ref><ref id="B45-ijms-23-15713"><label>45.</label><element-citation publication-type="book"><person-group person-group-type="author">
<name><surname>Kieser</surname><given-names>T.</given-names></name>
<name><surname>Bibb</surname><given-names>M.J.</given-names></name>
<name><surname>Buttner</surname><given-names>M.J.</given-names></name>
<name><surname>Chater</surname><given-names>K.F.</given-names></name>
<name><surname>Hopwood</surname><given-names>D.A.</given-names></name>
</person-group><source>Practical Streptomyces Genetics</source><publisher-name>John Innes Foundation</publisher-name><publisher-loc>Norwich, UK</publisher-loc><year>2000</year></element-citation></ref><ref id="B46-ijms-23-15713"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Gregory</surname><given-names>M.A.</given-names></name>
<name><surname>Till</surname><given-names>R.</given-names></name>
<name><surname>Smith</surname><given-names>M.C.M.</given-names></name>
</person-group><article-title>Integration site for <italic toggle="yes">Streptomyces</italic> phage &#x003c6;BT1 and development of site-specific integrating vectors</article-title><source>J. Bacteriol.</source><year>2003</year><volume>185</volume><fpage>5320</fpage><lpage>5323</lpage><pub-id pub-id-type="doi">10.1128/JB.185.17.5320-5323.2003</pub-id><?supplied-pmid 12923110?><pub-id pub-id-type="pmid">12923110</pub-id></element-citation></ref><ref id="B47-ijms-23-15713"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Yushchuk</surname><given-names>O.</given-names></name>
<name><surname>Vior</surname><given-names>N.M.</given-names></name>
<name><surname>Andreo-Vidal</surname><given-names>A.</given-names></name>
<name><surname>Berini</surname><given-names>F.</given-names></name>
<name><surname>R&#x000fc;ckert</surname><given-names>C.</given-names></name>
<name><surname>Busche</surname><given-names>T.</given-names></name>
<name><surname>Binda</surname><given-names>E.</given-names></name>
<name><surname>Kalinowski</surname><given-names>J.</given-names></name>
<name><surname>Truman</surname><given-names>A.W.</given-names></name>
<name><surname>Marinelli</surname><given-names>F.</given-names></name>
</person-group><article-title>Genomic-led discovery of a novel glycopeptide antibiotic by <italic toggle="yes">Nonomuraea coxensis</italic> DSM 45129</article-title><source>ACS Chem. Biol.</source><year>2021</year><volume>16</volume><fpage>915</fpage><lpage>928</lpage><pub-id pub-id-type="doi">10.1021/acschembio.1c00170</pub-id><pub-id pub-id-type="pmid">33913701</pub-id></element-citation></ref><ref id="B48-ijms-23-15713"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Yushchuk</surname><given-names>O.</given-names></name>
<name><surname>Ostash</surname><given-names>B.</given-names></name>
<name><surname>Truman</surname><given-names>A.W.</given-names></name>
<name><surname>Marinelli</surname><given-names>F.</given-names></name>
<name><surname>Fedorenko</surname><given-names>V.</given-names></name>
</person-group><article-title>Teicoplanin biosynthesis: Unraveling the interplay of structural, regulatory, and resistance genes</article-title><source>Appl. Microbiol. Biotechnol.</source><year>2020</year><volume>104</volume><fpage>3279</fpage><lpage>3291</lpage><pub-id pub-id-type="doi">10.1007/s00253-020-10436-y</pub-id><pub-id pub-id-type="pmid">32076781</pub-id></element-citation></ref><ref id="B49-ijms-23-15713"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Donadio</surname><given-names>S.</given-names></name>
<name><surname>Sosio</surname><given-names>M.</given-names></name>
<name><surname>Stegmann</surname><given-names>E.</given-names></name>
<name><surname>Weber</surname><given-names>T.</given-names></name>
<name><surname>Wohlleben</surname><given-names>W.</given-names></name>
</person-group><article-title>Comparative analysis and insights into the evolution of gene clusters for glycopeptide antibiotic biosynthesis</article-title><source>Mol. Genet. Genom.</source><year>2005</year><volume>274</volume><fpage>40</fpage><lpage>50</lpage><pub-id pub-id-type="doi">10.1007/s00438-005-1156-3</pub-id></element-citation></ref><ref id="B50-ijms-23-15713"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Yushchuk</surname><given-names>O.</given-names></name>
<name><surname>Zhukrovska</surname><given-names>K.</given-names></name>
<name><surname>Berini</surname><given-names>F.</given-names></name>
<name><surname>Fedorenko</surname><given-names>V.</given-names></name>
<name><surname>Marinelli</surname><given-names>F.</given-names></name>
</person-group><article-title>Genetics behind the glycosylation patterns in the biosynthesis of dalbaheptides</article-title><source>Front. Chem.</source><year>2022</year><volume>10</volume><fpage>858708</fpage><pub-id pub-id-type="doi">10.3389/fchem.2022.858708</pub-id><pub-id pub-id-type="pmid">35402387</pub-id></element-citation></ref><ref id="B51-ijms-23-15713"><label>51.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Truman</surname><given-names>A.W.</given-names></name>
<name><surname>Kwun</surname><given-names>M.J.</given-names></name>
<name><surname>Cheng</surname><given-names>J.</given-names></name>
<name><surname>Yang</surname><given-names>S.H.</given-names></name>
<name><surname>Suh</surname><given-names>J.W.</given-names></name>
<name><surname>Hong</surname><given-names>H.J.</given-names></name>
</person-group><article-title>Antibiotic resistance mechanisms inform discovery: Identification and characterization of a novel <italic toggle="yes">Amycolatopsis</italic> strain producing ristocetin</article-title><source>Antimicrob. Agents Chemother.</source><year>2014</year><volume>58</volume><fpage>5687</fpage><lpage>5695</lpage><pub-id pub-id-type="doi">10.1128/AAC.03349-14</pub-id><pub-id pub-id-type="pmid">25022591</pub-id></element-citation></ref><ref id="B52-ijms-23-15713"><label>52.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Yushchuk</surname><given-names>O.</given-names></name>
<name><surname>Ostash</surname><given-names>B.</given-names></name>
<name><surname>Pham</surname><given-names>T.H.</given-names></name>
<name><surname>Luzhetskyy</surname><given-names>A.</given-names></name>
<name><surname>Fedorenko</surname><given-names>V.</given-names></name>
<name><surname>Truman</surname><given-names>A.W.</given-names></name>
<name><surname>Horbal</surname><given-names>L.</given-names></name>
</person-group><article-title>Characterization of the post-assembly line tailoring processes in teicoplanin biosynthesis</article-title><source>ACS Chem. Biol.</source><year>2016</year><volume>11</volume><fpage>2254</fpage><lpage>2264</lpage><pub-id pub-id-type="doi">10.1021/acschembio.6b00018</pub-id><?supplied-pmid 27285718?><pub-id pub-id-type="pmid">27285718</pub-id></element-citation></ref><ref id="B53-ijms-23-15713"><label>53.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Xu</surname><given-names>M.</given-names></name>
<name><surname>Wang</surname><given-names>W.</given-names></name>
<name><surname>Waglechner</surname><given-names>N.</given-names></name>
<name><surname>Culp</surname><given-names>E.J.</given-names></name>
<name><surname>Guitor</surname><given-names>A.K.</given-names></name>
<name><surname>Wright</surname><given-names>G.D.</given-names></name>
</person-group><article-title>GPAHex&#x02014;A synthetic biology platform for type IV&#x02013;V glycopeptide antibiotic production and discovery</article-title><source>Nat. Commun.</source><year>2020</year><volume>11</volume><fpage>5232</fpage><pub-id pub-id-type="doi">10.1038/s41467-020-19138-5</pub-id><?supplied-pmid 33067466?><pub-id pub-id-type="pmid">33067466</pub-id></element-citation></ref><ref id="B54-ijms-23-15713"><label>54.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kruse</surname><given-names>T.</given-names></name>
<name><surname>Levisson</surname><given-names>M.</given-names></name>
<name><surname>de Vos</surname><given-names>W.M.</given-names></name>
<name><surname>Smidt</surname><given-names>H.</given-names></name>
</person-group><article-title><italic toggle="yes">vanI</italic>: A novel <sc>d</sc>-Ala-<sc>d</sc>-Lac vancomycin resistance gene cluster found in <italic toggle="yes">Desulfitobacterium hafniense</italic></article-title><source>Microb. Biotechnol.</source><year>2014</year><volume>7</volume><fpage>456</fpage><lpage>466</lpage><pub-id pub-id-type="doi">10.1111/1751-7915.12139</pub-id><pub-id pub-id-type="pmid">25042042</pub-id></element-citation></ref><ref id="B55-ijms-23-15713"><label>55.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Foucault</surname><given-names>M.-L.</given-names></name>
<name><surname>Courvalin</surname><given-names>P.</given-names></name>
<name><surname>Grillot-Courvalin</surname><given-names>C.</given-names></name>
</person-group><article-title>Fitness cost of VanA-type vancomycin resistance in methicillin-resistant <italic toggle="yes">Staphylococcus aureus</italic></article-title><source>Antimicrob. Agents Chemother.</source><year>2009</year><volume>53</volume><fpage>2354</fpage><lpage>2359</lpage><pub-id pub-id-type="doi">10.1128/AAC.01702-08</pub-id><?supplied-pmid 19332680?><pub-id pub-id-type="pmid">19332680</pub-id></element-citation></ref><ref id="B56-ijms-23-15713"><label>56.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Foucault</surname><given-names>M.-L.</given-names></name>
<name><surname>Depardieu</surname><given-names>F.</given-names></name>
<name><surname>Courvalin</surname><given-names>P.</given-names></name>
<name><surname>Grillot-Courvalin</surname><given-names>C.</given-names></name>
</person-group><article-title>Inducible expression eliminates the fitness cost of vancomycin resistance in enterococci</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>2010</year><volume>107</volume><fpage>16964</fpage><lpage>16969</lpage><pub-id pub-id-type="doi">10.1073/pnas.1006855107</pub-id><pub-id pub-id-type="pmid">20833818</pub-id></element-citation></ref><ref id="B57-ijms-23-15713"><label>57.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Heide</surname><given-names>L.</given-names></name>
</person-group><article-title>The aminocoumarins: Biosynthesis and biology</article-title><source>Nat. Prod. Rep.</source><year>2009</year><volume>26</volume><fpage>1241</fpage><lpage>1250</lpage><pub-id pub-id-type="doi">10.1039/b808333a</pub-id><pub-id pub-id-type="pmid">19779639</pub-id></element-citation></ref><ref id="B58-ijms-23-15713"><label>58.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Tamura</surname><given-names>K.</given-names></name>
<name><surname>Stecher</surname><given-names>G.</given-names></name>
<name><surname>Kumar</surname><given-names>S.</given-names></name>
</person-group><article-title>MEGA11: Molecular Evolutionary Genetics Analysis Version 11</article-title><source>Mol. Biol. Evol.</source><year>2021</year><volume>38</volume><fpage>3022</fpage><lpage>3027</lpage><pub-id pub-id-type="doi">10.1093/molbev/msab120</pub-id><pub-id pub-id-type="pmid">33892491</pub-id></element-citation></ref><ref id="B59-ijms-23-15713"><label>59.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Jones</surname><given-names>D.T.</given-names></name>
<name><surname>Taylor</surname><given-names>W.R.</given-names></name>
<name><surname>Thornton</surname><given-names>J.M.</given-names></name>
</person-group><article-title>The rapid generation of mutation data matrices from protein sequences</article-title><source>Bioinformatics</source><year>1992</year><volume>8</volume><fpage>275</fpage><lpage>282</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/8.3.275</pub-id></element-citation></ref><ref id="B60-ijms-23-15713"><label>60.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Sch&#x000e4;berle</surname><given-names>T.F.</given-names></name>
<name><surname>Vollmer</surname><given-names>W.</given-names></name>
<name><surname>Frasch</surname><given-names>H.J.</given-names></name>
<name><surname>H&#x000fc;ttel</surname><given-names>S.</given-names></name>
<name><surname>Kulik</surname><given-names>A.</given-names></name>
<name><surname>R&#x000f6;ttgen</surname><given-names>M.</given-names></name>
<name><surname>Von Thaler</surname><given-names>A.K.</given-names></name>
<name><surname>Wohlleben</surname><given-names>W.</given-names></name>
<name><surname>Stegmann</surname><given-names>E.</given-names></name>
</person-group><article-title>Self-resistance and cell wall composition in the glycopeptide producer <italic toggle="yes">Amycolatopsis balhimycina</italic></article-title><source>Antimicrob. Agents Chemother.</source><year>2011</year><volume>55</volume><fpage>4283</fpage><lpage>4289</lpage><pub-id pub-id-type="doi">10.1128/AAC.01372-10</pub-id><pub-id pub-id-type="pmid">21690280</pub-id></element-citation></ref><ref id="B61-ijms-23-15713"><label>61.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Frasch</surname><given-names>H.J.</given-names></name>
<name><surname>Kalan</surname><given-names>L.</given-names></name>
<name><surname>Kilian</surname><given-names>R.</given-names></name>
<name><surname>Martin</surname><given-names>T.</given-names></name>
<name><surname>Wright</surname><given-names>G.D.</given-names></name>
<name><surname>Stegmann</surname><given-names>E.</given-names></name>
</person-group><article-title>Alternative pathway to a glycopeptide-resistant cell wall in the balhimycin producer <italic toggle="yes">Amycolatopsis balhimycina</italic></article-title><source>ACS Infect. Dis.</source><year>2016</year><volume>1</volume><fpage>243</fpage><lpage>252</lpage><pub-id pub-id-type="doi">10.1021/acsinfecdis.5b00011</pub-id></element-citation></ref><ref id="B62-ijms-23-15713"><label>62.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Koshla</surname><given-names>O.</given-names></name>
<name><surname>Lopatniuk</surname><given-names>M.</given-names></name>
<name><surname>Rokytskyy</surname><given-names>I.</given-names></name>
<name><surname>Yushchuk</surname><given-names>O.</given-names></name>
<name><surname>Dacyuk</surname><given-names>Y.</given-names></name>
<name><surname>Fedorenko</surname><given-names>V.</given-names></name>
<name><surname>Luzhetskyy</surname><given-names>A.</given-names></name>
<name><surname>Ostash</surname><given-names>B.</given-names></name>
</person-group><article-title>Properties of <italic toggle="yes">Streptomyces albus</italic> J1074 mutant deficient in tRNA<sup>Leu</sup><sub>UAA</sub> gene <italic toggle="yes">bldA</italic></article-title><source>Arch. Microbiol.</source><year>2017</year><volume>199</volume><fpage>1175</fpage><lpage>1183</lpage><pub-id pub-id-type="doi">10.1007/s00203-017-1389-7</pub-id><?supplied-pmid 28528473?><pub-id pub-id-type="pmid">28528473</pub-id></element-citation></ref><ref id="B63-ijms-23-15713"><label>63.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Horbal</surname><given-names>L.</given-names></name>
<name><surname>Kobylyanskyy</surname><given-names>A.</given-names></name>
<name><surname>Yushchuk</surname><given-names>O.</given-names></name>
<name><surname>Zaburannyi</surname><given-names>N.</given-names></name>
<name><surname>Luzhetskyy</surname><given-names>A.</given-names></name>
<name><surname>Ostash</surname><given-names>B.</given-names></name>
<name><surname>Marinelli</surname><given-names>F.</given-names></name>
<name><surname>Fedorenko</surname><given-names>V.</given-names></name>
</person-group><article-title>Evaluation of heterologous promoters for genetic analysis of <italic toggle="yes">Actinoplanes teichomyceticus</italic>&#x02014;Producer of teicoplanin, drug of last defense</article-title><source>J. Biotechnol.</source><year>2013</year><volume>168</volume><fpage>367</fpage><lpage>372</lpage><pub-id pub-id-type="doi">10.1016/j.jbiotec.2013.10.018</pub-id><?supplied-pmid 24161919?><pub-id pub-id-type="pmid">24161919</pub-id></element-citation></ref><ref id="B64-ijms-23-15713"><label>64.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kearse</surname><given-names>M.</given-names></name>
<name><surname>Moir</surname><given-names>R.</given-names></name>
<name><surname>Wilson</surname><given-names>A.</given-names></name>
<name><surname>Stones-Havas</surname><given-names>S.</given-names></name>
<name><surname>Cheung</surname><given-names>M.</given-names></name>
<name><surname>Sturrock</surname><given-names>S.</given-names></name>
<name><surname>Buxton</surname><given-names>S.</given-names></name>
<name><surname>Cooper</surname><given-names>A.</given-names></name>
<name><surname>Markowitz</surname><given-names>S.</given-names></name>
<name><surname>Duran</surname><given-names>C.</given-names></name>
<etal/>
</person-group><article-title>Geneious Basic: An integrated and extendable desktop software platform for the organization and analysis of sequence data</article-title><source>Bioinformatics</source><year>2012</year><volume>28</volume><fpage>1647</fpage><lpage>1649</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/bts199</pub-id><?supplied-pmid 22543367?><pub-id pub-id-type="pmid">22543367</pub-id></element-citation></ref></ref-list></back><floats-group><fig position="float" id="ijms-23-15713-f001"><label>Figure 1</label><caption><p>Clustal Omega [<xref rid="B41-ijms-23-15713" ref-type="bibr">41</xref>] pairwise alignments of aa sequences of Tei3 and VanS<sub>Sc</sub> (<bold>a</bold>) as well as of Tei2 and VanR<sub>Sc</sub> (<bold>b</bold>). Domains and sequence features were annotated according to [<xref rid="B31-ijms-23-15713" ref-type="bibr">31</xref>] and CD-Search tool [<xref rid="B42-ijms-23-15713" ref-type="bibr">42</xref>]; SD&#x02014;sensor domain, TMH1/2&#x02014;first and second transmembrane &#x003b1;-helices, ESL&#x02014;extracytoplasmic sensory loop, ATPaseD&#x02014;ATPase domain, RD&#x02014;response domain, DBD&#x02014;DNA binding domain. In (<bold>a</bold>): mutation sites that were shown to impair VanS<sub>Sc</sub> function [<xref rid="B31-ijms-23-15713" ref-type="bibr">31</xref>] are highlighted in gray; the autophosphorylation site is highlighted in red; conserved ATP-binding sites are in blue. In (<bold>b</bold>): residues putatively involved in dimerization are highlighted in gray, while the phosphorylation site is in red.</p></caption><graphic xlink:href="ijms-23-15713-g001" position="float"/></fig><fig position="float" id="ijms-23-15713-f002"><label>Figure 2</label><caption><p>Expression of <italic toggle="yes">tei3</italic> led to teicoplanin and A40926 resistance in <italic toggle="yes">S. coelicolor</italic> M512. A number of 10<sup>6</sup> spores of <italic toggle="yes">S. coelicolor</italic> M512 and M101 were inoculated at each sector of SMMS agar plates added with vancomycin, teicoplanin, and A40926. Plates were examined after 72 h of incubation. <italic toggle="yes">S. coelicolor</italic> M512 was resistant to vancomycin and sensitive to teicoplanin and A40926, as previously reported [<xref rid="B43-ijms-23-15713" ref-type="bibr">43</xref>], whereas M101 was resistant to vancomycin, A40926, and teicoplanin.</p></caption><graphic xlink:href="ijms-23-15713-g002" position="float"/></fig><fig position="float" id="ijms-23-15713-f003"><label>Figure 3</label><caption><p><italic toggle="yes">gusA</italic>-based GPA-inducible reporter assay revealed a constitutive phosphorylase activity of Tei3. <italic toggle="yes">S. coelicolor</italic> strains pGJp<sup>+</sup> and M1J were inoculated on SMMS agar added with 25 &#x000b5;g/mL of X-Gluc along with their <italic toggle="yes">gusA</italic>-control strains, i.e., the teicoplanin/A40926-sensitive M512 and the teicoplanin/A40926-resistant M111. Notably, in pGJp<sup>+</sup>, the chromogenic conversion of X-Gluc (observed as green halos) occurred only upon GPA induction, while the background of M1J remained completely green, implying that Tei3 did not require GPA induction of its activity. A number of 10<sup>7</sup> spores of each strain were used for inoculation and the plate was examined after 48 h of incubation.</p></caption><graphic xlink:href="ijms-23-15713-g003" position="float"/></fig><fig position="float" id="ijms-23-15713-f004"><label>Figure 4</label><caption><p>Loss of the gene fragments coding for transmembrane helices and extracytoplasmic sensory loops makes <italic toggle="yes">tei3</italic> and <italic toggle="yes">vanS<sub>Sc</sub></italic> non-functional. A number of 10<sup>6</sup> spores were inoculated at each sector of SMMS agar plates added with vancomycin, teicoplanin, or A40926; plates were examined after 72 h of incubation. All the recombinant strains deriving from M512 were vancomycin-resistant and teicoplanin- and A40926-sensitive, whereas all the recombinant strains deriving from J3200 were resistant to all the tested GPAs.</p></caption><graphic xlink:href="ijms-23-15713-g004" position="float"/></fig><fig position="float" id="ijms-23-15713-f005"><label>Figure 5</label><caption><p>Hybrid SHK containing SD from Tei3 and ATPaseD from VanS<sub>Sc</sub> made <italic toggle="yes">S. coelicolor</italic> J3200 sensitive to teicoplanin and vancomycin, and <italic toggle="yes">S. coelicolor</italic> M512 sensitive to vancomycin, but resistant to A40926, implying that Tei3 SD recognized A40926 as a ligand. A number of 10<sup>6</sup> spores were inoculated at each sector of SMMS agar plates added with vancomycin, teicoplanin, or A40926; plates were examined after 72 h of incubation.</p></caption><graphic xlink:href="ijms-23-15713-g005" position="float"/></fig><table-wrap position="float" id="ijms-23-15713-t001"><object-id pub-id-type="pii">ijms-23-15713-t001_Table 1</object-id><label>Table 1</label><caption><p>Plasmids and bacterial strains used or generated in this study.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Name</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Characteristic</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Reference</th></tr></thead><tbody><tr><td align="center" valign="middle" rowspan="1" colspan="1">Plasmids:</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">pSET152A</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x003c6;C31-based integrative plasmid, pSET152 derivative carrying <italic toggle="yes">aac(3)IVp</italic> from pIJ773, Am<sup>r</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B63-ijms-23-15713" ref-type="bibr">63</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">pKC1132</td><td align="center" valign="middle" rowspan="1" colspan="1">suicide vector, Am<sup>r</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B45-ijms-23-15713" ref-type="bibr">45</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">pRT801</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x003c6;BT1-based integrative plasmid, Am<sup>r</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B46-ijms-23-15713" ref-type="bibr">46</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">pGUS</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x003c6;C31-based integrative plasmid, pSET152 derivative containing promoterless GusA, Am<sup>r</sup>, Sp<sup>r</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B44-ijms-23-15713" ref-type="bibr">44</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">pGP101</td><td align="center" valign="middle" rowspan="1" colspan="1">pSET152A derivative carrying <italic toggle="yes">tei3</italic></td><td align="center" valign="middle" rowspan="1" colspan="1">this work</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">pGP111</td><td align="center" valign="middle" rowspan="1" colspan="1">pRT801 derivative carrying <italic toggle="yes">tei3</italic></td><td align="center" valign="middle" rowspan="1" colspan="1">this work</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">pGP102</td><td align="center" valign="middle" rowspan="1" colspan="1">pSET152A derivative carrying SCO3589 (<italic toggle="yes">vanS<sub>Sc</sub>)</italic></td><td align="center" valign="middle" rowspan="1" colspan="1">this work</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">pKC1132-102</td><td align="center" valign="middle" rowspan="1" colspan="1">pKC1132 derivative carrying SCO3589 (<italic toggle="yes">vanS<sub>Sc</sub></italic>)</td><td align="center" valign="middle" rowspan="1" colspan="1">this work</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">pKC1132-103</td><td align="center" valign="middle" rowspan="1" colspan="1">pKC1132 derivative carrying hybrid SHK gene with <italic toggle="yes">tei3</italic>-SD and <italic toggle="yes">vanS<sub>Sc</sub></italic>-ATPaseD</td><td align="center" valign="middle" rowspan="1" colspan="1">this work</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">pGP103</td><td align="center" valign="middle" rowspan="1" colspan="1">pSET152A derivative carrying hybrid SHK gene with <italic toggle="yes">tei3</italic>-SD and <italic toggle="yes">vanS<sub>Sc</sub></italic>-ATPaseD</td><td align="center" valign="middle" rowspan="1" colspan="1">this work</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">pGP104</td><td align="center" valign="middle" rowspan="1" colspan="1">pSET152A derivative carrying <italic toggle="yes">tei3</italic>&#x02032;</td><td align="center" valign="middle" rowspan="1" colspan="1">this work</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">pGP105</td><td align="center" valign="middle" rowspan="1" colspan="1">pSET152A derivative carrying SCO3589&#x02032;</td><td align="center" valign="middle" rowspan="1" colspan="1">this work</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">pGP106</td><td align="center" valign="middle" rowspan="1" colspan="1">pSET152A derivative carrying <italic toggle="yes">tei3</italic>&#x02033;</td><td align="center" valign="middle" rowspan="1" colspan="1">this work</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">pGP107</td><td align="center" valign="middle" rowspan="1" colspan="1">pSET152A derivative carrying SCO3589&#x02033;</td><td align="center" valign="middle" rowspan="1" colspan="1">this work</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">pGJp</td><td align="center" valign="middle" rowspan="1" colspan="1">pGUS derivative carrying <italic toggle="yes">vanJp</italic></td><td align="center" valign="middle" rowspan="1" colspan="1">this work</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">pHJp</td><td align="center" valign="middle" rowspan="1" colspan="1">pGUS derivative carrying <italic toggle="yes">vanHp</italic></td><td align="center" valign="middle" rowspan="1" colspan="1">this work</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Strains:</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><italic toggle="yes">A. teichomyceticus</italic> ATCC 31121</td><td align="center" valign="middle" rowspan="1" colspan="1">wild type, teicoplanin producer</td><td align="center" valign="middle" rowspan="1" colspan="1">ATCC</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><italic toggle="yes">S. coelicolor</italic> M512</td><td align="center" valign="middle" rowspan="1" colspan="1">A3(2) derivative, &#x00394;<italic toggle="yes">redD</italic> &#x00394;<italic toggle="yes">actII-ORF4</italic> SCP1<sup>&#x02212;</sup> SCP2<sup>&#x02212;</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B38-ijms-23-15713" ref-type="bibr">38</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><italic toggle="yes">S. coelicolor</italic> J3200</td><td align="center" valign="middle" rowspan="1" colspan="1">A3(2) derivative, &#x00394;<italic toggle="yes">SCO3589</italic> (<italic toggle="yes">vanS<sub>Sc</sub></italic>)</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B31-ijms-23-15713" ref-type="bibr">31</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><italic toggle="yes">S. coelicolor</italic> M101</td><td align="center" valign="middle" rowspan="1" colspan="1">M512 derivative carrying pGP101</td><td align="center" valign="middle" rowspan="1" colspan="1">this work</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><italic toggle="yes">S. coelicolor</italic> M111</td><td align="center" valign="middle" rowspan="1" colspan="1">M512 derivative carrying pGP111</td><td align="center" valign="middle" rowspan="1" colspan="1">this work</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><italic toggle="yes">S. coelicolor</italic> pGJp<sup>+</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">M512 derivative carrying pGJp</td><td align="center" valign="middle" rowspan="1" colspan="1">this work</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><italic toggle="yes">S. coelicolor</italic> pGHp<sup>+</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">M512 derivative carrying pGHp</td><td align="center" valign="middle" rowspan="1" colspan="1">this work</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><italic toggle="yes">S. coelicolor</italic> M1J</td><td align="center" valign="middle" rowspan="1" colspan="1">M512 derivative carrying pGJp and pGP111</td><td align="center" valign="middle" rowspan="1" colspan="1">this work</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><italic toggle="yes">S. coelicolor</italic> M103</td><td align="center" valign="middle" rowspan="1" colspan="1">M512 derivative carrying pGP103</td><td align="center" valign="middle" rowspan="1" colspan="1">this work</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><italic toggle="yes">S. coelicolor</italic> M104</td><td align="center" valign="middle" rowspan="1" colspan="1">M512 derivative carrying pGP104</td><td align="center" valign="middle" rowspan="1" colspan="1">this work</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><italic toggle="yes">S. coelicolor</italic> M105</td><td align="center" valign="middle" rowspan="1" colspan="1">M512 derivative carrying pGP105</td><td align="center" valign="middle" rowspan="1" colspan="1">this work</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><italic toggle="yes">S. coelicolor</italic> M106</td><td align="center" valign="middle" rowspan="1" colspan="1">M512 derivative carrying pGP106</td><td align="center" valign="middle" rowspan="1" colspan="1">this work</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><italic toggle="yes">S. coelicolor</italic> M107</td><td align="center" valign="middle" rowspan="1" colspan="1">M512 derivative carrying pGP107</td><td align="center" valign="middle" rowspan="1" colspan="1">this work</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><italic toggle="yes">S. coelicolor</italic> J103</td><td align="center" valign="middle" rowspan="1" colspan="1">J3200 derivative carrying pGP103</td><td align="center" valign="middle" rowspan="1" colspan="1">this work</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><italic toggle="yes">S. coelicolor</italic> J104</td><td align="center" valign="middle" rowspan="1" colspan="1">J3200 derivative carrying pGP104</td><td align="center" valign="middle" rowspan="1" colspan="1">this work</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><italic toggle="yes">S. coelicolor</italic> J105</td><td align="center" valign="middle" rowspan="1" colspan="1">J3200 derivative carrying pGP105</td><td align="center" valign="middle" rowspan="1" colspan="1">this work</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><italic toggle="yes">S. coelicolor</italic> J106</td><td align="center" valign="middle" rowspan="1" colspan="1">J3200 derivative carrying pGP106</td><td align="center" valign="middle" rowspan="1" colspan="1">this work</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">S. coelicolor</italic> J107</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">J3200 derivative carrying pGP107</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">this work</td></tr></tbody></table></table-wrap><table-wrap position="float" id="ijms-23-15713-t002"><object-id pub-id-type="pii">ijms-23-15713-t002_Table 2</object-id><label>Table 2</label><caption><p>Oligonucleotide primers used in this study.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Name</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Sequence (5&#x02032;-3&#x02032;) *</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Purpose</th></tr></thead><tbody><tr><td align="center" valign="middle" rowspan="1" colspan="1">tei3_sdomain_PaeI</td><td align="center" valign="middle" rowspan="1" colspan="1">CGAGCATGCGACCGGCCAG</td><td align="center" valign="middle" rowspan="1" colspan="1">Reverse primer for cloning the <italic toggle="yes">tei3</italic> region coding for the sensor domain</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">tei3_F</td><td align="center" valign="middle" rowspan="1" colspan="1">TTTGATATC<named-content content-type="color:red">GGAGG</named-content>GAGACCGTGGACCGAGCCC</td><td align="center" valign="middle" rowspan="1" colspan="1">Cloning of the <italic toggle="yes">tei3</italic> and its truncated versions</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">tei3&#x02019;_F</td><td align="center" valign="middle" rowspan="1" colspan="1">TTTGATATC<named-content content-type="color:red">GGAGG</named-content>GAGACC<underline>GTG</underline>TTCGCCCCGGCGACGG</td><td align="center" valign="middle" rowspan="1" colspan="1">-//-</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">tei3&#x0201d;_F</td><td align="center" valign="middle" rowspan="1" colspan="1">TTTGATATC<named-content content-type="color:red">GGAGG</named-content>AGACC<underline>GTG</underline>GGTCGGATGCTCGCTCCTCT</td><td align="center" valign="middle" rowspan="1" colspan="1">-//-</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">tei3_R</td><td align="center" valign="middle" rowspan="1" colspan="1">TTTGAATTCGCGGTGGGCGGTTCAGTTT</td><td align="center" valign="middle" rowspan="1" colspan="1">-//-</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">SCO3589_F</td><td align="center" valign="middle" rowspan="1" colspan="1">TTTGATATC<named-content content-type="color:red">GGAGG</named-content>GCGACGGTGGATAGGCGCC</td><td align="center" valign="middle" rowspan="1" colspan="1">Cloning of the <italic toggle="yes">SCO3589 (vanS<sub>Sc</sub>)</italic> and its truncated versions</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">SCO3589&#x02019;_F</td><td align="center" valign="middle" rowspan="1" colspan="1">TTTGATATC<named-content content-type="color:red">GGAGG</named-content>GAGACC<underline>GTG</underline>CTTCGCAGTTTCGCCC</td><td align="center" valign="middle" rowspan="1" colspan="1">-//-</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">SCO3589&#x02019;&#x02019;_F</td><td align="center" valign="middle" rowspan="1" colspan="1">TTTGATATC<named-content content-type="color:red">GGAGG</named-content>GCGACG<underline>GTG</underline>GGACGCATGCTCGCCCCCCT</td><td align="center" valign="middle" rowspan="1" colspan="1">-//-</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">SCO3589_R</td><td align="center" valign="middle" rowspan="1" colspan="1">TTTGAATTCTGGCGCTCACCTGCCGGTG</td><td align="center" valign="middle" rowspan="1" colspan="1">-//-</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">vanHp_KpnI_F</td><td align="center" valign="middle" rowspan="1" colspan="1">TTTGGTACCTACGTCCACACCGCCGAGC</td><td align="center" valign="middle" rowspan="1" colspan="1">Cloning of <italic toggle="yes">vanH<sub>Sc</sub></italic> promoter region into pGUS</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">vanHp_SpeI_R</td><td align="center" valign="middle" rowspan="1" colspan="1">TTTACTAGTGCCGTCCCGTATGCGCTTT</td><td align="center" valign="middle" rowspan="1" colspan="1">-//-</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">vanJp_KpnI_F</td><td align="center" valign="middle" rowspan="1" colspan="1">TTTGGTACCACACTCAGCAGCTCCAACG</td><td align="center" valign="middle" rowspan="1" colspan="1">Cloning of <italic toggle="yes">vanJ<sub>Sc</sub></italic> promoter region into pGUS</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">vanJp_SpeI_R</td><td align="center" valign="middle" rowspan="1" colspan="1">TTTACTAGTCTGGCGCCGGTGCGGCCGA</td><td align="center" valign="middle" rowspan="1" colspan="1">-//-</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">aac(3)IV_F</td><td align="center" valign="middle" rowspan="1" colspan="1">ATCGACTGATGTCATCAGCG</td><td align="center" valign="middle" rowspan="1" colspan="1">Diagnostic primers for the amplification of <italic toggle="yes">aac(3)IV</italic> gene</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">aac(3)IV_R</td><td align="center" valign="middle" rowspan="1" colspan="1">CGAGCTGAAGAAAGACAAT</td><td align="center" valign="middle" rowspan="1" colspan="1">-//-</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">gusA_ver_F</td><td align="center" valign="middle" rowspan="1" colspan="1">GGCGGCTACACGCCCTTCGA</td><td align="center" valign="middle" rowspan="1" colspan="1">Diagnostic primers for the amplification of 1000 bp internal region of <italic toggle="yes">gusA</italic></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">gusA_ver_R</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">TGATGGGCCGGGTGGGGTC</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-//-</td></tr></tbody></table><table-wrap-foot><fn><p>* artificial ribosome binding sites are highlighted in red and artificial start codons are underlined.</p></fn></table-wrap-foot></table-wrap></floats-group></article>